WO2022145483A1 - 甘味の増大した経口組成物 - Google Patents
甘味の増大した経口組成物 Download PDFInfo
- Publication number
- WO2022145483A1 WO2022145483A1 PCT/JP2021/048993 JP2021048993W WO2022145483A1 WO 2022145483 A1 WO2022145483 A1 WO 2022145483A1 JP 2021048993 W JP2021048993 W JP 2021048993W WO 2022145483 A1 WO2022145483 A1 WO 2022145483A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sweetness
- oral composition
- phospholipids
- points
- sweetener
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 243
- 230000001965 increasing effect Effects 0.000 title description 39
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 262
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 195
- 239000003765 sweetening agent Substances 0.000 claims abstract description 195
- 235000019640 taste Nutrition 0.000 claims abstract description 129
- 235000013361 beverage Nutrition 0.000 claims description 154
- 235000013353 coffee beverage Nutrition 0.000 claims description 52
- 229930006000 Sucrose Natural products 0.000 claims description 41
- 239000005720 sucrose Substances 0.000 claims description 41
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 40
- 239000004615 ingredient Substances 0.000 claims description 40
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 37
- 229930195729 fatty acid Natural products 0.000 claims description 37
- 239000000194 fatty acid Substances 0.000 claims description 37
- 150000004665 fatty acids Chemical class 0.000 claims description 33
- 235000013336 milk Nutrition 0.000 claims description 29
- 239000008267 milk Substances 0.000 claims description 29
- 210000004080 milk Anatomy 0.000 claims description 29
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 28
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 28
- 239000008103 glucose Substances 0.000 claims description 27
- 235000010469 Glycine max Nutrition 0.000 claims description 26
- 244000068988 Glycine max Species 0.000 claims description 26
- 239000000463 material Substances 0.000 claims description 21
- 240000002791 Brassica napus Species 0.000 claims description 17
- 235000004977 Brassica sinapistrum Nutrition 0.000 claims description 17
- 235000003222 Helianthus annuus Nutrition 0.000 claims description 17
- 238000004519 manufacturing process Methods 0.000 claims description 16
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 14
- 241000533293 Sesbania emerus Species 0.000 claims description 14
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 13
- 235000020124 milk-based beverage Nutrition 0.000 claims description 11
- 239000005715 Fructose Substances 0.000 claims description 10
- 229930091371 Fructose Natural products 0.000 claims description 10
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 10
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 10
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 9
- 241000517645 Abra Species 0.000 claims description 8
- 241001133760 Acoelorraphe Species 0.000 claims description 8
- 230000001149 cognitive effect Effects 0.000 claims description 8
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 7
- WQZGKKKJIJFFOK-IVMDWMLBSA-N D-allopyranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-IVMDWMLBSA-N 0.000 claims description 7
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 7
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims description 7
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- 239000008101 lactose Substances 0.000 claims description 7
- 229920000742 Cotton Polymers 0.000 claims description 6
- LKDRXBCSQODPBY-JDJSBBGDSA-N D-allulose Chemical compound OCC1(O)OC[C@@H](O)[C@@H](O)[C@H]1O LKDRXBCSQODPBY-JDJSBBGDSA-N 0.000 claims description 6
- 102000002322 Egg Proteins Human genes 0.000 claims description 6
- 108010000912 Egg Proteins Proteins 0.000 claims description 6
- 241000219146 Gossypium Species 0.000 claims description 6
- 235000004431 Linum usitatissimum Nutrition 0.000 claims description 6
- 240000006240 Linum usitatissimum Species 0.000 claims description 6
- 235000003434 Sesamum indicum Nutrition 0.000 claims description 6
- 240000008042 Zea mays Species 0.000 claims description 6
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 6
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 6
- 235000005822 corn Nutrition 0.000 claims description 6
- 235000013345 egg yolk Nutrition 0.000 claims description 6
- 210000002969 egg yolk Anatomy 0.000 claims description 6
- 235000019534 high fructose corn syrup Nutrition 0.000 claims description 6
- 240000007817 Olea europaea Species 0.000 claims description 5
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 4
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 4
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 claims description 3
- BJHIKXHVCXFQLS-PQLUHFTBSA-N keto-D-tagatose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-PQLUHFTBSA-N 0.000 claims description 3
- 239000004922 lacquer Substances 0.000 claims description 3
- 235000013322 soy milk Nutrition 0.000 claims description 3
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 claims 1
- 244000020551 Helianthus annuus Species 0.000 claims 1
- 244000000231 Sesamum indicum Species 0.000 claims 1
- 239000000284 extract Substances 0.000 description 67
- 235000009508 confectionery Nutrition 0.000 description 64
- 239000000523 sample Substances 0.000 description 58
- 238000012360 testing method Methods 0.000 description 55
- 238000000034 method Methods 0.000 description 52
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 51
- 238000011156 evaluation Methods 0.000 description 40
- 239000000126 substance Substances 0.000 description 39
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 36
- 150000002632 lipids Chemical class 0.000 description 35
- 241000954177 Bangana ariza Species 0.000 description 30
- 241000723377 Coffea Species 0.000 description 30
- 235000016213 coffee Nutrition 0.000 description 30
- 230000001953 sensory effect Effects 0.000 description 29
- RYCNUMLMNKHWPZ-SNVBAGLBSA-N 1-acetyl-sn-glycero-3-phosphocholine Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C RYCNUMLMNKHWPZ-SNVBAGLBSA-N 0.000 description 28
- 235000013305 food Nutrition 0.000 description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 27
- 230000002708 enhancing effect Effects 0.000 description 26
- 241000196324 Embryophyta Species 0.000 description 24
- 241000894007 species Species 0.000 description 24
- -1 acidulants Substances 0.000 description 22
- 235000000346 sugar Nutrition 0.000 description 20
- 238000004458 analytical method Methods 0.000 description 19
- 230000000694 effects Effects 0.000 description 19
- 235000008504 concentrate Nutrition 0.000 description 18
- 239000012141 concentrate Substances 0.000 description 18
- 239000002994 raw material Substances 0.000 description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 16
- 241000208818 Helianthus Species 0.000 description 16
- 235000013399 edible fruits Nutrition 0.000 description 16
- 235000010436 thaumatin Nutrition 0.000 description 15
- 239000000892 thaumatin Substances 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- ARGKVCXINMKCAZ-UZRWAPQLSA-N neohesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@H]3[C@@H]([C@H](O)[C@@H](O)[C@H](C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UZRWAPQLSA-N 0.000 description 13
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 13
- 244000228451 Stevia rebaudiana Species 0.000 description 12
- 239000012086 standard solution Substances 0.000 description 12
- 235000021588 free fatty acids Nutrition 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 239000011734 sodium Substances 0.000 description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 10
- 239000000538 analytical sample Substances 0.000 description 10
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 10
- 229910052708 sodium Inorganic materials 0.000 description 10
- 229930189775 mogroside Natural products 0.000 description 9
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 9
- 235000014171 carbonated beverage Nutrition 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- 235000011187 glycerol Nutrition 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 235000019202 steviosides Nutrition 0.000 description 8
- 150000008163 sugars Chemical class 0.000 description 8
- 235000013616 tea Nutrition 0.000 description 8
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 7
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 7
- 244000269722 Thea sinensis Species 0.000 description 7
- 239000000787 lecithin Substances 0.000 description 7
- 229940067606 lecithin Drugs 0.000 description 7
- 235000010445 lecithin Nutrition 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 239000004386 Erythritol Substances 0.000 description 6
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical group OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 6
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 6
- 235000019414 erythritol Nutrition 0.000 description 6
- 229940009714 erythritol Drugs 0.000 description 6
- YLRFCQOZQXIBAB-RBZZARIASA-N fluoxymesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1CC[C@](C)(O)[C@@]1(C)C[C@@H]2O YLRFCQOZQXIBAB-RBZZARIASA-N 0.000 description 6
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 6
- 229960004949 glycyrrhizic acid Drugs 0.000 description 6
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 6
- 235000019410 glycyrrhizin Nutrition 0.000 description 6
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 238000010187 selection method Methods 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 150000005846 sugar alcohols Chemical class 0.000 description 6
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 5
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 5
- 239000004378 Glycyrrhizin Substances 0.000 description 5
- 244000040738 Sesamum orientale Species 0.000 description 5
- 244000179853 Sideroxylon dulcificum Species 0.000 description 5
- 235000011341 Sideroxylon dulcificum Nutrition 0.000 description 5
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 5
- 230000001476 alcoholic effect Effects 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 235000015872 dietary supplement Nutrition 0.000 description 5
- 239000008123 high-intensity sweetener Substances 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 235000019533 nutritive sweetener Nutrition 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 229960002920 sorbitol Drugs 0.000 description 5
- 229940013618 stevioside Drugs 0.000 description 5
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 5
- 239000011550 stock solution Substances 0.000 description 5
- 235000021091 sugar-based sweeteners Nutrition 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 241000722718 Capparis masaikai Species 0.000 description 4
- 241000218165 Dioscoreophyllum Species 0.000 description 4
- 241000202807 Glycyrrhiza Species 0.000 description 4
- 240000006284 Molineria latifolia Species 0.000 description 4
- 241001092459 Rubus Species 0.000 description 4
- YWPVROCHNBYFTP-UHFFFAOYSA-N Rubusoside Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC1OC(CO)C(O)C(O)C1O YWPVROCHNBYFTP-UHFFFAOYSA-N 0.000 description 4
- 235000006468 Thea sinensis Nutrition 0.000 description 4
- 244000185386 Thladiantha grosvenorii Species 0.000 description 4
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 description 4
- CWRILEGKIAOYKP-SSDOTTSWSA-M [(2r)-3-acetyloxy-2-hydroxypropyl] 2-aminoethyl phosphate Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCCN CWRILEGKIAOYKP-SSDOTTSWSA-M 0.000 description 4
- 235000013405 beer Nutrition 0.000 description 4
- 238000011088 calibration curve Methods 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 108010010165 curculin Proteins 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 235000015203 fruit juice Nutrition 0.000 description 4
- 150000002327 glycerophospholipids Chemical class 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 229920001542 oligosaccharide Polymers 0.000 description 4
- 239000006072 paste Substances 0.000 description 4
- YWPVROCHNBYFTP-OSHKXICASA-N rubusoside Chemical compound O([C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YWPVROCHNBYFTP-OSHKXICASA-N 0.000 description 4
- 150000004671 saturated fatty acids Chemical class 0.000 description 4
- 239000000600 sorbitol Substances 0.000 description 4
- 235000010356 sorbitol Nutrition 0.000 description 4
- QSIDJGUAAUSPMG-CULFPKEHSA-N steviolmonoside Chemical compound O([C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O QSIDJGUAAUSPMG-CULFPKEHSA-N 0.000 description 4
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 4
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 4
- SRBFZHDQGSBBOR-SOOFDHNKSA-N D-ribopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@@H]1O SRBFZHDQGSBBOR-SOOFDHNKSA-N 0.000 description 3
- 235000001950 Elaeis guineensis Nutrition 0.000 description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 description 3
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 3
- 208000007976 Ketosis Diseases 0.000 description 3
- 241000157406 Pentadiplandra brazzeana Species 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 239000004383 Steviol glycoside Substances 0.000 description 3
- 239000004376 Sucralose Substances 0.000 description 3
- 240000006365 Vitis vinifera Species 0.000 description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 3
- 235000013334 alcoholic beverage Nutrition 0.000 description 3
- 229910000147 aluminium phosphate Chemical group 0.000 description 3
- 239000008122 artificial sweetener Substances 0.000 description 3
- 235000021311 artificial sweeteners Nutrition 0.000 description 3
- 235000020279 black tea Nutrition 0.000 description 3
- 229960001948 caffeine Drugs 0.000 description 3
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 150000002584 ketoses Chemical class 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 229940069445 licorice extract Drugs 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 3
- 238000010606 normalization Methods 0.000 description 3
- 150000002482 oligosaccharides Chemical class 0.000 description 3
- ALAGDBVXZZADSN-UHFFFAOYSA-N pentazine Chemical compound C1=NN=NN=N1 ALAGDBVXZZADSN-UHFFFAOYSA-N 0.000 description 3
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 235000019411 steviol glycoside Nutrition 0.000 description 3
- 229930182488 steviol glycoside Natural products 0.000 description 3
- 150000008144 steviol glycosides Chemical class 0.000 description 3
- 235000019408 sucralose Nutrition 0.000 description 3
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 210000001779 taste bud Anatomy 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 239000000811 xylitol Substances 0.000 description 3
- 235000010447 xylitol Nutrition 0.000 description 3
- 229960002675 xylitol Drugs 0.000 description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- WWUZIQQURGPMPG-UHFFFAOYSA-N (-)-D-erythro-Sphingosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)CO WWUZIQQURGPMPG-UHFFFAOYSA-N 0.000 description 2
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 2
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 2
- ZPDQFUYPBVXUKS-YADHBBJMSA-N 1-stearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)COP(O)(=O)OC[C@H](N)C(O)=O ZPDQFUYPBVXUKS-YADHBBJMSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- LKDRXBCSQODPBY-OEXCPVAWSA-N D-tagatose Chemical compound OCC1(O)OC[C@@H](O)[C@H](O)[C@@H]1O LKDRXBCSQODPBY-OEXCPVAWSA-N 0.000 description 2
- 244000127993 Elaeis melanococca Species 0.000 description 2
- 239000001329 FEMA 3811 Substances 0.000 description 2
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 2
- 101000659765 Homo sapiens Taste receptor type 1 member 2 Proteins 0.000 description 2
- 101000659774 Homo sapiens Taste receptor type 1 member 3 Proteins 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- BJHIKXHVCXFQLS-ZXEDONINSA-N L-psicose Chemical compound OC[C@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-ZXEDONINSA-N 0.000 description 2
- 244000292467 Lippia dulcis Species 0.000 description 2
- 235000000144 Lippia dulcis Nutrition 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 101000865553 Pentadiplandra brazzeana Defensin-like protein Proteins 0.000 description 2
- WINXNKPZLFISPD-UHFFFAOYSA-M Saccharin sodium Chemical compound [Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 WINXNKPZLFISPD-UHFFFAOYSA-M 0.000 description 2
- QFVOYBUQQBFCRH-UHFFFAOYSA-N Steviol Natural products C1CC2(C3)CC(=C)C3(O)CCC2C2(C)C1C(C)(C(O)=O)CCC2 QFVOYBUQQBFCRH-UHFFFAOYSA-N 0.000 description 2
- OMHUCGDTACNQEX-OSHKXICASA-N Steviolbioside Natural products O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O OMHUCGDTACNQEX-OSHKXICASA-N 0.000 description 2
- 102100035948 Taste receptor type 1 member 2 Human genes 0.000 description 2
- 102100035942 Taste receptor type 1 member 3 Human genes 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- ATBOMIWRCZXYSZ-XZBBILGWSA-N [1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (9e,12e)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC ATBOMIWRCZXYSZ-XZBBILGWSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 150000001323 aldoses Chemical class 0.000 description 2
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 2
- 239000000605 aspartame Substances 0.000 description 2
- 235000010357 aspartame Nutrition 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 229960003438 aspartame Drugs 0.000 description 2
- 235000008452 baby food Nutrition 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- JLPRGBMUVNVSKP-AHUXISJXSA-M chembl2368336 Chemical compound [Na+].O([C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C([O-])=O)[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O JLPRGBMUVNVSKP-AHUXISJXSA-M 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 235000020510 functional beverage Nutrition 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 2
- 150000003271 galactooligosaccharides Chemical class 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 108091005708 gustatory receptors Proteins 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 150000002402 hexoses Chemical class 0.000 description 2
- 235000015243 ice cream Nutrition 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 235000021539 instant coffee Nutrition 0.000 description 2
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 229940010454 licorice Drugs 0.000 description 2
- 235000020888 liquid diet Nutrition 0.000 description 2
- UOXRPRZMAROFPH-IESLQMLBSA-N lysophosphatidylinositol Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)COP(O)(=O)OC1[C@H](O)[C@@H](O)C(O)[C@@H](O)[C@H]1O UOXRPRZMAROFPH-IESLQMLBSA-N 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000002324 mouth wash Substances 0.000 description 2
- 239000005445 natural material Substances 0.000 description 2
- 235000021096 natural sweeteners Nutrition 0.000 description 2
- ITVGXXMINPYUHD-CUVHLRMHSA-N neohesperidin dihydrochalcone Chemical compound C1=C(O)C(OC)=CC=C1CCC(=O)C(C(=C1)O)=C(O)C=C1O[C@H]1[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ITVGXXMINPYUHD-CUVHLRMHSA-N 0.000 description 2
- 229940089953 neohesperidin dihydrochalcone Drugs 0.000 description 2
- 235000010434 neohesperidine DC Nutrition 0.000 description 2
- 235000019520 non-alcoholic beverage Nutrition 0.000 description 2
- 150000002972 pentoses Chemical class 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 229940127557 pharmaceutical product Drugs 0.000 description 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
- 150000003905 phosphatidylinositols Chemical class 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 235000021067 refined food Nutrition 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 210000000697 sensory organ Anatomy 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 150000003408 sphingolipids Chemical class 0.000 description 2
- WWUZIQQURGPMPG-KRWOKUGFSA-N sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 description 2
- 235000011496 sports drink Nutrition 0.000 description 2
- QFVOYBUQQBFCRH-VQSWZGCSSA-N steviol Chemical compound C([C@@]1(O)C(=C)C[C@@]2(C1)CC1)C[C@H]2[C@@]2(C)[C@H]1[C@](C)(C(O)=O)CCC2 QFVOYBUQQBFCRH-VQSWZGCSSA-N 0.000 description 2
- 229940032084 steviol Drugs 0.000 description 2
- 150000003445 sucroses Chemical class 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 150000003538 tetroses Chemical class 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 238000002137 ultrasound extraction Methods 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- RMLYXMMBIZLGAQ-UHFFFAOYSA-N (-)-monatin Natural products C1=CC=C2C(CC(O)(CC(N)C(O)=O)C(O)=O)=CNC2=C1 RMLYXMMBIZLGAQ-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- WRPAFPPCKSYACJ-ZBYJYCAASA-N (2r,3r,4s,5s,6r)-2-[[(2r,3s,4s,5r,6r)-6-[[(3s,8r,9r,10s,11r,13r,14s,17r)-17-[(5r)-5-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-hydroxy-6-methylheptan-2-yl]-11-hydrox Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H](CCC(C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]6[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O6)O)O5)O)CC4)(C)C)=CC[C@@H]3[C@]2(C)CC1)C)C(C)(C)O)[C@H]1O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]1O WRPAFPPCKSYACJ-ZBYJYCAASA-N 0.000 description 1
- GHBNZZJYBXQAHG-KUVSNLSMSA-N (2r,3r,4s,5s,6r)-2-[[(2r,3s,4s,5r,6r)-6-[[(3s,8s,9r,10r,11r,13r,14s,17r)-17-[(2r,5r)-5-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-3-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H](CC[C@@H](C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]6[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O6)O)O5)O)CC4)(C)C)=CC[C@H]3[C@]2(C)CC1)C)C(C)(C)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GHBNZZJYBXQAHG-KUVSNLSMSA-N 0.000 description 1
- RMLYXMMBIZLGAQ-HZMBPMFUSA-N (2s,4s)-4-amino-2-hydroxy-2-(1h-indol-3-ylmethyl)pentanedioic acid Chemical compound C1=CC=C2C(C[C@](O)(C[C@H](N)C(O)=O)C(O)=O)=CNC2=C1 RMLYXMMBIZLGAQ-HZMBPMFUSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 1
- AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 1
- XVTAQSGZOGYIEY-UHFFFAOYSA-N 3,4-dihydroisocoumarin Chemical compound C1=CC=C2C(=O)OCCC2=C1 XVTAQSGZOGYIEY-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 241000228031 Coffea liberica Species 0.000 description 1
- 241000272201 Columbiformes Species 0.000 description 1
- YTBSYETUWUMLBZ-UHFFFAOYSA-N D-Erythrose Natural products OCC(O)C(O)C=O YTBSYETUWUMLBZ-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-KAZBKCHUSA-N D-altritol Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KAZBKCHUSA-N 0.000 description 1
- YTBSYETUWUMLBZ-IUYQGCFVSA-N D-erythrose Chemical compound OC[C@@H](O)[C@@H](O)C=O YTBSYETUWUMLBZ-IUYQGCFVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- BJHIKXHVCXFQLS-PUFIMZNGSA-N D-psicose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C(=O)CO BJHIKXHVCXFQLS-PUFIMZNGSA-N 0.000 description 1
- LKDRXBCSQODPBY-IANNHFEVSA-N D-sorbose Chemical compound OCC1(O)OC[C@@H](O)[C@H](O)[C@H]1O LKDRXBCSQODPBY-IANNHFEVSA-N 0.000 description 1
- YTBSYETUWUMLBZ-QWWZWVQMSA-N D-threose Chemical compound OC[C@@H](O)[C@H](O)C=O YTBSYETUWUMLBZ-QWWZWVQMSA-N 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 240000003133 Elaeis guineensis Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010056474 Erythrosis Diseases 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VSOAQEOCSA-N L-altropyranose Chemical compound OC[C@@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-VSOAQEOCSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 101710084933 Miraculin Proteins 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 241000207836 Olea <angiosperm> Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000157404 Pentadiplandra Species 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 241000299590 Sclerochiton ilicifolius Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 235000006092 Stevia rebaudiana Nutrition 0.000 description 1
- 208000025371 Taste disease Diseases 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- FYGDTMLNYKFZSV-DZOUCCHMSA-N alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-DZOUCCHMSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 238000001479 atomic absorption spectroscopy Methods 0.000 description 1
- 235000015241 bacon Nutrition 0.000 description 1
- 210000000270 basal cell Anatomy 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- 235000020289 caffè mocha Nutrition 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000020152 coffee milk drink Nutrition 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- ZGSPNIOCEDOHGS-UHFFFAOYSA-L disodium [3-[2,3-di(octadeca-9,12-dienoyloxy)propoxy-oxidophosphoryl]oxy-2-hydroxypropyl] 2,3-di(octadeca-9,12-dienoyloxy)propyl phosphate Chemical compound [Na+].[Na+].CCCCCC=CCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COP([O-])(=O)OCC(O)COP([O-])(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC ZGSPNIOCEDOHGS-UHFFFAOYSA-L 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 235000015897 energy drink Nutrition 0.000 description 1
- 229940031098 ethanolamine Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000014080 ginger ale Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- MNQZXJOMYWMBOU-UHFFFAOYSA-N glyceraldehyde Chemical compound OCC(O)C=O MNQZXJOMYWMBOU-UHFFFAOYSA-N 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 229940072008 glycyrrhiza glabra extract Drugs 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 239000000833 heterodimer Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- 235000015094 jam Nutrition 0.000 description 1
- 210000001847 jaw Anatomy 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- BJHIKXHVCXFQLS-LFRDXLMFSA-N keto-L-tagatose Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)C(=O)CO BJHIKXHVCXFQLS-LFRDXLMFSA-N 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 1
- 229960000511 lactulose Drugs 0.000 description 1
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 235000021577 malt beverage Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 235000019656 metallic taste Nutrition 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- JLYBBRAAICDTIS-UHFFFAOYSA-N mogrol Natural products CC12C(O)CC3(C)C(C(CCC(O)C(C)(C)O)C)CCC3(C)C1CC=C1C2CCC(O)C1(C)C JLYBBRAAICDTIS-UHFFFAOYSA-N 0.000 description 1
- 229930191869 mogroside IV Natural products 0.000 description 1
- OKGRRPCHOJYNKX-UHFFFAOYSA-N mogroside IV A Natural products C1CC2(C)C3CC=C(C(C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)C(CO)O5)O)O4)O)CC4)(C)C)C4C3(C)C(O)CC2(C)C1C(C)CCC(C(C)(C)O)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O OKGRRPCHOJYNKX-UHFFFAOYSA-N 0.000 description 1
- WRPAFPPCKSYACJ-UHFFFAOYSA-N mogroside IV E Natural products C1CC2(C)C3CC=C(C(C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)C(CO)O5)O)O4)O)CC4)(C)C)C4C3(C)C(O)CC2(C)C1C(C)CCC(C(C)(C)O)OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O WRPAFPPCKSYACJ-UHFFFAOYSA-N 0.000 description 1
- TVJXHJAWHUMLLG-UHFFFAOYSA-N mogroside V Natural products CC(CCC(OC1OC(COC2OC(CO)C(O)C(O)C2OC3OC(CO)C(O)C(O)C3O)C(O)C(O)C1O)C(C)(C)O)C4CCC5(C)C6CC=C7C(CCC(OC8OC(COC9OC(CO)C(O)C(O)C9O)C(O)C(O)C8O)C7(C)C)C6(C)C(O)CC45C TVJXHJAWHUMLLG-UHFFFAOYSA-N 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 239000013588 oral product Substances 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 210000003254 palate Anatomy 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 125000004437 phosphorous atom Chemical group 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 229960001462 sodium cyclamate Drugs 0.000 description 1
- 239000000176 sodium gluconate Substances 0.000 description 1
- 229940005574 sodium gluconate Drugs 0.000 description 1
- 235000012207 sodium gluconate Nutrition 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 235000021147 sweet food Nutrition 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 210000000225 synapse Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000005182 tip of the tongue Anatomy 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 235000012184 tortilla Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- CCXAYLQLOLXXKE-DWJAGBRCSA-K trisodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4s,5s,6s)-2-[[(3s,4ar,6ar,6bs,8as,11s,12ar,14ar,14bs)-11-carboxylato-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1h-picen-3-yl]oxy]-6-carboxylato-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-t Chemical compound [Na+].[Na+].[Na+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C([O-])=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O CCXAYLQLOLXXKE-DWJAGBRCSA-K 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 235000012431 wafers Nutrition 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 229960003487 xylose Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F5/00—Coffee; Coffee substitutes; Preparations thereof
- A23F5/24—Extraction of coffee; Coffee extracts; Making instant coffee
- A23F5/243—Liquid, semi-liquid or non-dried semi-solid coffee extract preparations; Coffee gels; Liquid coffee in solid capsules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F5/00—Coffee; Coffee substitutes; Preparations thereof
- A23F5/46—Coffee flavour; Coffee oil; Flavouring of coffee or coffee extract
- A23F5/465—Flavouring with flavours other than natural coffee flavour or coffee oil
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
- A23L27/36—Terpene glycosides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/88—Taste or flavour enhancing agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/03—Organic compounds
- A23L29/05—Organic compounds containing phosphorus as heteroatom
Definitions
- the present invention relates to an oral composition having an increased sweetness, a method for producing the oral composition, a method for enhancing the sweetness of the oral composition, a concentrate for providing the oral composition, and the like.
- Taste receptors that receive taste are called taste buds, and are present in the mushroom-shaped papillae that exist in a wide range around the tip of the tongue, and the circumvallate papillae and foliate papillae that exist in a limited area in the back of the tongue.
- taste buds are cell aggregates composed of elongated taste cells and basal cells. Taste cells produce fine line hair toward the tongue surface, and at the bottom of the cell, they form synapses with taste nerve fibers that enter the taste buds, and the taste we usually feel is sent to the brain via the taste nerve as taste information and recognized.
- T1R2 and T1R3 are known as sweet taste receptors. It has been reported that T1R2 and T1R3 form a heterodimer (Non-Patent Documents 1 to 3).
- the present inventors have succeeded for the first time in increasing the sweetness of a high-sweetness sweetener by blending a low-concentration heterologous phospholipid that is not perceived by humans.
- the present invention includes the following aspects of the invention.
- (a) High-sweetness sweetener in an amount equivalent to sweetness intensity X1 It contains (b) unique phospholipids and (c) heterologous phospholipids below the taste cognitive threshold.
- the oral composition according to [1] wherein the phospholipid has a fatty acid having 16 or more carbon atoms.
- [3] The oral composition according to [1] or [2], further comprising a low-sweetness sweetener.
- the oral composition according to paragraph 1 comprises a low-sweetness sweetener selected from glucose, sucrose, fructose, maltose, high fructose corn syrup, lactose, psicose, allose, tagatose, xylose, ribose and combinations thereof.
- the unique phospholipid is a phospholipid derived from coffee beans
- the heterologous phospholipid is a material selected from soybean, rapeseed, sunflower, abra palm, sesame, corn, lacquer, olive, cotton, flax, egg yolk and milk.
- the method for producing an oral composition according to any one of [1] to [8], which comprises.
- [10] In the production of oral compositions containing unique phospholipids The sweetness of an oral composition imparted by a high sweetness sweetener, comprising (a) adding a high sweetness sweetener above the taste recognition threshold and (b) adding a phospholipid below the taste recognition threshold. How to enhance.
- An oral composition comprising (b) a unique phospholipid and (c) a phospholipid of less than about 250 ⁇ g / mL.
- the present invention provides an oral composition having an enhanced sweetness and texture, rather than a simple sweetness as obtained by increasing the amount of a high-sweetness sweetener used.
- FIG. 1 is a graph showing the concentration of free fatty acid in each lipid sample.
- FIG. 2 is a graph showing the peak area value after normalization of LPC in each lipid sample.
- FIG. 3 is a graph showing the peak area value after normalization of PC in each lipid sample.
- FIG. 4 is a diagram showing an increase in the texture of a sweet beverage containing rebaugioside D due to phospholipids derived from soybean (A), oil palm (B), rapeseed (C) and sunflower (D).
- FIG. 5 is a diagram showing an increase in the texture of a sweet beverage containing mogroside V due to phospholipids derived from soybean.
- FIG. 6 is a diagram showing an increase in the texture of a sweet beverage containing rebaugioside D due to phospholipids derived from soybean.
- the description that "the content of the A component is X mg / 100 mL" relating to the beverage means that "X mg of the A component is contained in 100 mL of the beverage". Since the specific gravity of a beverage is approximately 1, "mg / 100g” can be equated with "mg / 100mL” in a beverage. If it is not appropriate to express the denominator of a unit by volume, such as in a solid composition, the denominator shall be read as mass (for example, “mg / 100mL” shall be read as "mg / 100g”). Further, for example, the description that "the content of the B component is Yppm" relating to the beverage means that "the B component is contained in Yppm with respect to the total amount (100% by mass) of the beverage”.
- oral composition of the present invention provides, as a first aspect, the following oral composition (hereinafter referred to as "oral composition of the present invention").
- A High-sweetness sweetener in an amount equivalent to sweetness intensity X1 It contains (b) unique phospholipids and (c) heterologous phospholipids below the taste cognitive threshold.
- the sweetness of the sweetness intensity X2 produced by the combination of the high sweetness sweetener in an amount equivalent to the component (a) sweetness intensity X1 and the phospholipid peculiar to the component (b) is the component (c).
- the presence of heterologous phospholipids below the taste recognition threshold increases the sweetness intensity to X3 (where 0.1 ⁇ X2 ⁇ X3).
- sweeteners, acidulants, flavors, vitamins, pigments, antioxidants, preservatives, seasonings, extracts, and pH adjusters other than the component (a) May contain additional ingredients such as quality stabilizers.
- the oral composition according to one aspect of the present invention does not contain (a) a sweetening component other than a high-sweetness sweetener in an amount equivalent to the sweetness intensity X1 as a sweetener.
- the oral composition according to another aspect of the present invention may contain (a) a sweetening component other than a high-sweetness sweetener in an amount equivalent to the sweetness intensity X1 as a sweetener.
- oral composition is a general term for solids, semi-solids, semi-fluids, and liquids, and mixtures thereof, which are orally edible.
- the oral composition of the present invention includes foods, and foods include beverages.
- Examples of the oral composition of the present invention include general foods, dietary supplements, health foods, functional foods, infant foods, elderly foods and the like.
- Dietary supplements are foods that are fortified with specific nutritional components.
- Health foods are foods that are healthy or considered to be good for health, and include dietary supplements, natural foods, diet foods, and the like.
- Functional foods are foods for supplementing nutritional components that fulfill the body's regulatory function, and are synonymous with foods for specified health uses.
- Infant food is food for children up to about 6 years old.
- Foods for the elderly are foods that have been processed so that they are easier to digest and absorb than untreated foods.
- the form of the oral composition is not particularly limited and may be various forms. Examples of such forms include beverages, confectionery, supplements and the like.
- the beverage may be either an alcoholic beverage or a non-alcoholic beverage.
- Non-alcoholic beverages include, for example, non-alcoholic beer, malt beverage, lactic acid bacterium beverage, cocoa, sports drink, nutritional drink, tea-based beverage, coffee beverage, carbonated beverage, functional beverage, fruit / vegetable beverage, dairy beverage, milky beverage. Beverages, flavored waters, soymilk beverages and the like can be mentioned, but are not limited thereto.
- Coffee beverages are beverage products manufactured using coffee as a raw material.
- the type of product is not particularly limited, but for example, “coffee”, “coffee drink”, “soft drink with coffee”, “carbonated drink with coffee”, which are the definitions of "Fair Competition Code for Labeling Coffee Beverages” in Japan. , “Caffeine-less coffee” and the like are included. Even among beverages made from coffee, those with a milk solid content of 3.0% by mass or more are subject to the "Fair Competition Code for Labeling Drinking Milk” in Japan and may be treated as "milk beverages”. be.
- the coffee component (sometimes referred to as an extract of roasted coffee beans in the present specification) refers to a solution containing components derived from coffee beans, for example, a coffee extract, that is, roasted and crushed. Examples thereof include a solution obtained by extracting the coffee beans with water or hot water. Further, a solution obtained by adjusting an appropriate amount of coffee extract obtained by concentrating coffee extract, instant coffee obtained by drying coffee extract, or the like with water or warm water can also be mentioned as coffee content.
- the type of coffee beans used for coffee beverages is not particularly limited.
- Examples of the cultivated tree species include Arabica, Robusta, and Coffea liberica, and examples of coffee varieties include Mocha, Brazil, Colombia, Guatemala, Blue Mountain, Kona, Mandelin, and Kilimanjaro.
- One type of coffee beans may be used, or a plurality of types may be blended and used.
- There are no particular restrictions on the roasting method of roasted coffee beans there are no restrictions on the roasting temperature or roasting environment, and the usual method can be adopted, but the roasting degree L value of coffee beans is 18 to 24. preferable. Furthermore, there are no restrictions on the extraction method from the roasted coffee beans.
- water or warm water (0 to 100 ° C) is used from crushed roasted coffee beans that have been coarsely ground, medium-ground, or finely ground.
- the extraction method may be a drip type, a siphon type, a boiling type, a jet type, a continuous type or the like.
- the coffee beverage of the present invention may contain decaffeination or caffeine, and the concentration when caffeine is contained is not particularly limited, but is preferably about 40 mg / 100 mL to 100 mg / 100 mL.
- the chlorogenic acid concentration of the coffee beverage of the present invention is not particularly limited, but is preferably about 15 to 85 mg / 100 mL.
- the form of the coffee beverage is not limited, and may be, for example, a beverage in which concentrated coffee extract or instant coffee is dissolved, or a packaged coffee beverage that is sealed in a container such as a can or a PET bottle. good.
- non-alcoholic beer in the present specification means a carbonated drink having a beer-like flavor, and is a non-fermented non-alcoholic type, which does not substantially contain alcohol.
- non-alcoholic beer does not exclude beverages containing a very small amount of alcohol that cannot be detected.
- composition of the present invention is a tea-based beverage
- it is preferably a black tea beverage or a sugar-free tea beverage.
- sugar-free tea beverage examples include green tea beverage, oolong tea beverage, barley tea beverage, brown rice tea beverage, pigeon barley tea beverage, sugar-free black tea beverage and the like.
- black tea beverages include milk tea and the like.
- the form of the carbonated drink is preferably a cola flavored drink, a clear carbonated drink, a ginger ale, a fruit juice-based carbonated drink, a milk-containing carbonated drink, or a sugar-free carbonated drink.
- Functional beverages include sports drinks, energy drinks, health support beverages and pouch jelly beverages.
- fruit / vegetable beverages include 100% fruit juice beverages, fruit-containing beverages, low-fruit juice-containing refreshing beverages, fruit-containing fruit beverages, and fruit meat beverages.
- Milk beverages include coffee milk, fruit milk and the like, and milk beverages include lactic acid bacteria beverages, milk-containing refreshing beverages and the like. Milk beverages contain ingredients with a milk solid content of 3.0% or more by weight, according to Japan's "Fair Competition Code for Labeling of Drinking Milk".
- Alcoholic beverages refer to beverages containing alcoholic ingredients.
- the alcohol raw material include brewed liquor, distilled liquor, mixed liquor and the like.
- Examples of brewed liquor include wine and beer.
- the alcoholic beverage may contain alcohol in a detectable amount, and for example, it contains 1% by volume or more, 2% by volume or more, 3% by volume or more, 4% by volume or more, and 5% by volume or more of alcohol. ..
- processed foods include processed foods of grains, seafood and meat (bread, noodles, tortillas, pasta, ham, bacon, sausages, kamaboko, fried heavens, hanpen, etc.).
- confectionery include, but are not limited to, candy, jam, chewing gum, ice cream, snack confectionery, cookies, biscuits, cakes, wafers, sweet buns, chocolate, and Japanese confectionery.
- the oral compositions of the present invention also include fine granules, tablets, granules, powders, capsules (including soft capsules and hard capsules), chewables, syrups, mouthwashes, toothpastes, oral ointments, mouthwashes, etc. It may be in the form of a drug such as a throat spray or a non-pharmaceutical product, or a naturally liquid food containing the composition of the present invention in proteins, sugars, fats, trace elements, vitamins, emulsifiers, fragrances, etc. It may be a processed form such as a liquid diet, a semi-solid diet, a semi-digested nutritional diet, a component nutritional diet, a drink, and an enteral nutritional supplement.
- the present invention comprises components (a) to (c), and the amount of the component (c) is less than the taste recognition threshold, a drug, a non-pharmaceutical product, a naturally liquid diet, a semi-digestive nutritional diet, and an ingredient.
- Oral products such as nutritional foods, drinks, and enteral nutritional supplements are also provided.
- Oral substances are a general term for substances that are introduced into the mouth regardless of ingestion. Further, the oral composition of the present invention may be packaged and sterilized.
- sweetness intensity means the intensity of sweetness exhibited by a substance.
- sweetness degree 1 the sweetness degree of glucose is 0.6 to 0.7 (median value 0.65).
- the oral composition of the present invention contains a high-sweetness sweetener in an amount equivalent to the sweetness intensity X1, and the sweetness of the sweetness intensity X2 according to the components (a) and (b), according to the components (a) to (c).
- the sweetness intensity X3 is exhibited, and 0.1 ⁇ X2 ⁇ X3.
- the high sweetness sweetener of the component (a) contains a combination of a plurality of sweeteners
- the amount of the high sweetness sweetener in the component (a) is the amount of the combination of all the sweeteners.
- X1 of "Sweetness intensity X1" is more than 0.1 and 0.5 or less, more than 0.1 and 1.0 or less, more than 0.1 and 1.5 or less, more than 0.1 and 2.0 or less, more than 0.1 and 2.5 or less, more than 0.1 and 3.0 or less, more than 0.1 and 3.5 or less, More than 0.1 and 4.0 or less, more than 0.1 and 4.5 or less, more than 0.1 and 5.0 or less, more than 0.1 and 5.5 or less, 0.5 to 1.0, 0.5 to 1.5, 0.5 to 2.0, 0.5 to 2.5, 0.5 to 3.0, 0.5 to 3.5, 0.5 to 4.0, 0.5-4.5, 0.5-5.0, 0.5-5.5, 1.0-1.5, 1.0-2.0, 1.0-2.5, 1.0-3.0, 1.0-3.5, 1.0-4.0, 1.0-4.5, 1.0-5.0, 1.0-5.5, 1.5-2.0, 1.5-2.5, 1.5-3.0, 1.5-3.5, 1.5-4.0, 1.5-4.5, 1.5-5.0, 1.5-
- X1 is also more than 0.1 and 6.0 or less, 0.1 and 6.5 or less, 0.1 and 7.0 or less, 0.1 and 7.5 or less, 0.1 and 8.0 or less, 0.1 and 8.5 or less, 0.1 or 9.0 or less, 0.1 or more and 9.5.
- 0.1 to 10.0 or less 0.1 to 10.5 or less, 0.1 to 11.0 or less, 0.1 to 11.5 or less, 0.1 to 12.0 or less, 0.1 to 13.0 or less, 0.1 to 14.0 or less, 0.1 to 15.0 or less, More than 0.1 and 16.0 or less, more than 0.1 and 17.0 or less, more than 0.1 and 18.0 or less, 0.5 to 6.0, 0.5 to 6.5, 0.5 to 7.0, 0.5 to 7.5, 0.5 to 8.0, 0.5 to 8.5, 0.5 to 9.0, 0.5 to 9.5, 0.5-10.0, 0.5-10.5, 0.5-11.0, 0.5-11.5, 0.5-12.0, 0.5-13.0, 0.5-14.0, 0.5-15.0, 0.5-16.0, 0.5-17.0, 0.5-18.0, 1.0-6.0, 1.0- 6.5, 1.0-7.0, 1.0-7.5, 1.0-8.0, 1.0-8.5, 1.0-9.0, 1.0-9.5, 1.0-10.0, 1.0-10.5, 1.0-10.5,
- the amount equivalent to the sweetness intensity X1 of the high sweetness sweetener means the amount that exhibits the sweetness of the sweetness intensity X1 under the condition that the high sweetness sweetener is dissolved in water at 20 ° C. having the same volume as the oral composition of the present invention. ..
- the amount of the high-sweetness sweetener may be Pappm, where Pappm is an amount equivalent to the sweetness intensity X1.
- Pa is about 1 to about 800, about 5 to about 800, about 10 to about 800, about 15 to about 800, about 20 to about 800, about 25 to about 800, about 30 to about 800, about 35 to.
- Pa is also 1-1500, 1-1200, 5-1200, 1-1000, 5-1000, 10-1000, 1-900, 5-900, 10-900, 15-900, 20-900, 25- 900, 30-900, 35-900, 40-900, 45-900, 50-900, 55-900, 1-800, 5-800, 10-800, 15-800, 20-800, 25-800, 30-800, 35-800, 40-800, 45-800, 50-800, 55-800, 1-700, 5-700, 10-700, 15-700, 20-700, 25-700, 30- 700, 35-700, 40-700, 45-700, 50-700, 55-700, 1-600, 5-600, 10-600, 15-600, 20-600, 25-600, 30-600, 35-600, 40-600, 45-600, 50-600, 55-600, 1-550, 1-540, 1-530, 1-520, 1-510, 1-505, 1-500, 1- 495, 1-490, 5-550, 5-540, 5-530, 5-520, 5-510, 5-505, 5-500, 5-495
- Pa is also about 100-about 500, about 100-about 450, about 100-about 400, about 100-about 350, about 100-about 300, about 100-about 250, about 100-about 200, about 150-about. 500, about 150 to about 450, about 150 to about 400, about 150 to about 350, about 150 to about 300, about 150 to about 250, about 150 to about 200, about 200 to about 500, about 200 to about 450, It can take values of about 200 to about 400, about 200 to about 350, about 200 to about 300, and about 200 to about 250.
- X2 is more than 0.1 and 0.5 or less, more than 0.1 and 1.0 or less, more than 0.1 and 1.5 or less, more than 0.1 and 2.0 or less, more than 0.1 and 2.5 or less, more than 0.1 and 3.0 or less, more than 0.1 and 3.5 or less, more than 0.1 and 4.0 or less, More than 0.1 and less than 4.5, more than 0.1 and less than 5.0, more than 0.1 and less than 5.5, 0.5 to 1.0, 0.5 to 1.5, 0.5 to 2.0, 0.5 to 2.5, 0.5 to 3.0, 0.5 to 3.5, 0.5 to 4.0, 0.5 to 4.5, 0.5-5.0, 0.5-5.5, 1.0-1.5, 1.0-2.0, 1.0-2.5, 1.0-3.0, 1.0-3.5, 1.0-4.0, 1.0-4.5, 1.0-5.0, 1.0-5.5, 1.5-2.0, 1.5- 2.5, 1.5-3.0, 1.5-3.5, 1.5-4.0, 1.5-4.5, 1.5-5.0, 1.5-5.5, 2.0-2.5, 2.0-3.0,
- X2 also exceeds 0.1 and 6.0 or less, 0.1 and 6.5 or less, 0.1 and 7.0 or less, 0.1 and 7.5 or less, 0.1 and 8.0 or less, 0.1 and 8.5 or less, 0.1 or 9.0 or less, 0.1 or more and 9.5.
- 0.1 to 10.0 or less 0.1 to 10.5 or less, 0.1 to 11.0 or less, 0.1 to 11.5 or less, 0.1 to 12.0 or less, 0.1 to 13.0 or less, 0.1 to 14.0 or less, 0.1 to 15.0 or less, More than 0.1 and 16.0 or less, more than 0.1 and 17.0 or less, more than 0.1 and 18.0 or less, 0.5 to 6.0, 0.5 to 6.5, 0.5 to 7.0, 0.5 to 7.5, 0.5 to 8.0, 0.5 to 8.5, 0.5 to 9.0, 0.5 to 9.5, 0.5-10.0, 0.5-10.5, 0.5-11.0, 0.5-11.5, 0.5-12.0, 0.5-13.0, 0.5-14.0, 0.5-15.0, 0.5-16.0, 0.5-17.0, 0.5-18.0, 1.0-6.0, 1.0- 6.5, 1.0-7.0, 1.0-7.5, 1.0-8.0, 1.0-8.5, 1.0-9.0, 1.0-9.5, 1.0-10.0, 1.0-10.5, 1.0-10.5,
- X3 is not particularly limited as long as it is larger than X2, but 0.5 to 6.0, 0.5 to 6.5, 0.5 to 7.0, 0.5 to 7.5, 0.5 to 8.0, 0.5 to 8.5, 0.5 to 9.0, 0.5 to 9.5, 0.5 to 10.0, 0.5.
- X3 is also 4.0-18, 4.0-16, 4.0-15.5, 4.0-14, 4.5-18, 4.5-16, 4.5-15.5, 4.5-14, 5.0-18, 5.0-16, 5.0-15.5, 5.0- 14, 5.5-18, 5.5-16, 5.5-15.5, 5.5-14, 6.0-18, 6.0-16, 6.0-15.5, 6.0-14, 6.5-18, 6.5-16, 6.5-15.5, 6.5-14, 7.0-18, 7.0-16, 7.0-15.5, 7.0-14, 7.5-18, 7.5-16, 7.5-15.5, 7.5-14, 7.5-9, 7.5-8, 8.0-18, 8.0-18, 8.0- 16, 8.0-15.5, 8.0-14, 8.5-18, 8.5-16, 8.5-15.5, 8.5-14, 9.0-18, 9.0-16, 9.0-15.5, 9.0-14, 9.5-18, 9.5-16, It may be 9.5 to 15.5, 9.5 to 14, 10.0 to 18, 10.0 to 16, 10.0 to 15.5, 10.5 to 18, 10.5 to 16 or 10.5 to 15.5.
- the oral composition of the present invention exhibits an enhanced sweetness. Whether or not the sweetness of the oral composition of the present invention is enhanced can be evaluated by panelists trained in sensory. Further, the sweetness intensity of the oral composition of the present invention is such that the standard oral composition (for example, a beverage) which is a reference for sweetness has a sweetness intensity of 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and so on.
- the oral composition of the present invention is prepared by shaking the sucrose concentration to 11, 12, 13, 14, 15 and the like, and the panelist compares the sweetness of the oral composition of the present invention with the sweetness of the standard oral composition. The sweetness of the composition can be measured.
- the standard oral composition for example, beverage having a sweetness intensity of 1, 2, ...
- sucrose 15 has a sucrose content of 1 g / 100 g, 2 g / 100 g, ... 15 g /, as compared with the oral composition to which sucrose is not added.
- the reference oral composition having less sweetness than the oral composition of the present invention in the above measurement the reference oral composition having the closest sweetness to the oral composition of the present invention is selected, and the selected reference oral composition is selected.
- sucrose By adding sucrose to the product, the sweetness is adjusted to be the same as that of the oral composition of the present invention, and at that time, the oral composition of the present invention is based on the sucrose content contained in the adjusted reference oral composition. It is also possible to measure the sweetness intensity of an object.
- VAS method sweetness intensity evaluation
- the evaluator defines the intensity of sweetness as "not sweet at all" at the lower end and "I can't think of anything sweeter than this" at the upper end. Evaluation is made by expressing the sweetness intensity felt at that time by expressing the intensity on a straight line using a paper on which a straight line is drawn.
- the level of sweetness intensity one of sweetness, not sweetness, and the same degree of sweetness as that of the standard oral composition is selected by sensory evaluation without quantifying the sweetness intensity of the test oral composition. It can also be determined by the limb forced selection method (3-AFC), the two-limb forced selection method (2-AFC) in which either sweet or not sweet is selected by sensory evaluation.
- the sensory evaluation may be performed by multiple panelists trained in sensory, and if at least one panelist evaluates it as "sweet", the test oral composition will have a higher sweetness intensity than the reference oral composition. Can be evaluated.
- test oral composition For example, about 10% or more, about 20% or more, about 25% or more, about 30% or more, about 33% or more, about 40% or more, about 50% or more, about 60% or more, about 67% or more, about panelists. If 70% or more, about 75% or more, about 80% or more, or about 90% or more evaluate the test oral composition as "sweeter" than the reference oral composition, the test oral composition is considered to be the reference oral composition. It can be evaluated that the sweetness intensity is higher than that. It is preferred to be rated "sweet" by more panelists.
- about 25% or more, about 33% or more, about 50% or more, about 67% or more, about 75% or more, about 80% or more or about 90% or more of the panelists are oral based on the test oral composition. Evaluated as "sweet” compared to the composition. In a particularly preferred embodiment, about 50% or more, about 67% or more, about 75% or more, about 80% or more or about 90% or more of the panelists say that the test oral composition is "sweeter" than the reference oral composition. evaluate.
- the sweetness intensity of the oral composition of the present invention is not particularly limited as long as it is acceptable as a food, and for example, the sweetness degree is 4.0 to 20, 4.0 to 15, 4.0 to 12.5, 4.0 to 10, 4.5 to 20. , 4.5-15, 4.5-12.5, 4.5-10, 5.0-20, 5.0-15, 5.0-12.5, 5.0-10, 5.5-20, 5.5-15, 5.5-12.5, 5.5-10, 6.0-20, 6.0 ⁇ 15, 6.0 ⁇ 12.5, 6.0 ⁇ 10, 6.5 ⁇ 20, 6.5 ⁇ 15, 6.5 ⁇ 12.5, 6.5 ⁇ 10, 7.0 ⁇ 20, 7.0 ⁇ 15, 7.0 ⁇ 12.5, 7.0 ⁇ 10, 7.5 ⁇ 20, 7.5 ⁇ 15 , 7.5 to 12.5, 7.5 to 10, 7.5 to 9, 7.5 to 8, 8.0 to 20, 8.0 to 20, 8.0 to 15, 8.0 to 12.5, 8.0 to 10, 8.5 to 20, 8.5 to 15, 8.5 to 12.5, 8.5 ⁇ 10, 9.0 ⁇ 20, 9.0 ⁇ 15, 9.0 ⁇ 12.5, 9.0
- the energy (total energy amount) of the oral composition of the present invention is 0 to 50 Kcal / 100 mL, 0 to 45 Kcal / 100 mL, 0 to 40 Kcal / 100 mL, 0 to 35 Kcal / 100 mL, 0 to 30 Kcal / 100 mL, 0 to 0 depending on the embodiment.
- the energy (total energy amount, TE) of the oral composition of the present invention is 0 ⁇ TE ⁇ 50 Kcal / 100 mL, 0 ⁇ TE ⁇ 45 Kcal / 100 mL, depending on the embodiment (for example, an embodiment containing a caloric sweetener).
- Ingredients (a) to (c) can be combined arbitrarily. As shown in Examples described later, the addition of the component (c) to the components (a) + (b) can result in a sweetness intensity X3 higher than the sweetness intensity X2 of the components (a) + (b) alone. can. That is, the sweetness of the component (a) can be enhanced by the component (c). Therefore, while maintaining the same sweetness as the oral composition containing sucrose, the oral composition such as food should be produced without using high-calorie sucrose or while reducing the amount used thereof. Can be done. Therefore, it is possible to design new low-calorie sweet foods and the like.
- a high-intensity sweetener such as rebaugioside D or rebaugioside M for component (a)
- D-allulose or erythritol as additional sweeteners.
- calorie sweeteners such as sucrose, glucose, fructose, and sorbitol as additional sweeteners.
- the oral composition of the present invention has an increased texture due to component (c).
- the texture of an oral composition is a factor relating to the physical properties of the taste of the oral composition, such as mouthfeel, thickness, body feel, mellowness, texture, mouthfeel, throat, texture, crispness, and texture.
- the texture can be evaluated by a sensory test, a texture measuring device (tensipressor), or the like. For liquid oral compositions such as beverages, evaluation by a sensory test is preferable.
- Whether or not the texture is increased by the component (c) is the same as the oral composition of the present invention and the oral composition of the present invention except that the component (c) is not contained, for example, by a panelist trained in sensory. It can be evaluated by comparing the oral composition of the composition (hereinafter, may be referred to as “control composition”) with respect to the item related to the texture.
- a method by the VAS method can be mentioned.
- the evaluator uses a piece of paper on which a straight line is drawn to show the degree of items related to the texture on a straight line, and the degree of items felt at that time is on the straight line. Evaluate by expressing by position. For example, for evaluation items such as "thickness”, “body feeling”, and “mellowness”, one end of the straight line is defined as “not felt at all” and the other end is defined as “very felt”, and the items felt during the test are linear.
- the texture has increased may be evaluated by comparing individual quantified items, or by comparing a plurality of items at the same time using a radar chart or the like.
- the evaluation on the radar chart can be performed by the evaluation based on the whole image (shape, etc.) or the evaluation based on the comparison of the area of the radar chart.
- the increase in texture is that the area of the radar chart for the oral composition containing the component (c) is larger than the area of the radar chart for the oral composition not containing the component (c).
- the oral composition of the invention has at least one of the endpoints of its texture increased over that of the control composition.
- the oral composition of the invention has at least one of the endpoints selected from its "mouthfeel", "thickness", “body feel” and “mellowness” than that of the control composition. It is increasing.
- the "mouthfeel" of the oral composition of the present invention is 0 points for the "mouthfeel” of the control oral composition, -3 points for "watery” than the control composition, and "syrup-like".
- the "thickness" of the oral composition of the present invention is 0 points for the "thickness” of the control oral composition, -3 points for "no feeling of thickness” for the control composition, and "very thick".
- the "body feeling" of the oral composition of the present invention is 0 points for the “body feeling” of the control oral composition, -3 points for "no body feeling” for the control composition, and ".
- the body very much as 3 points, 0.05 points or more, 0.08 points or more, 0.10 points or more, 0.13 points or more, 0.15 points or more, 0.18 points or more, 0.20 points or more, 0.23 points or more, 0.25 points or more, 0.28 points or more, 0.30 points or more, 0.33 points or more, 0.35 points or more, 0.38 points or more, 0.40 points or more, 0.43 points or more, 0.45 points or more, 0.48 points or more, 0.50 points or more, 0.53 points or more, 0.55 points Above, 0.58 points or above, 0.60 points or above, 0.63 points or above, 0.65 points or above, 0.68 points or above, 0.70 points or above, 0.73 points or above, 0.75 points or above, 0.78 points or above, 0.80 points
- the "mellowness" of the oral composition of the present invention is 0 points for “mellowness” of the control oral composition, -3 points for “not feeling mellowness” for the control composition, and " When evaluated by the VAS method with "I feel very mellow” as 3 points, 0.05 points or more, 0.08 points or more, 0.10 points or more, 0.13 points or more, 0.15 points or more, 0.18 points or more, 0.20 points or more, 0.23 points or more, 0.25 points or more, 0.28 points or more, 0.30 points or more, 0.33 points or more, 0.35 points or more, 0.38 points or more, 0.40 points or more, 0.43 points or more, 0.45 points or more, 0.48 points or more, 0.50 points or more, 0.53 points or more, 0.55 points Above, 0.58 points or above, 0.60 points or above, 0.63 points or above, 0.65 points or above, 0.68 points or above, 0.70 points or above, 0.73 points or above, 0.75 points or above, 0.78 points or above, 0.
- the area of the radar chart of the evaluation items relating to the texture of the oral composition of the present invention is the radar chart relating to the control composition.
- High sweetness sweetener in the present specification, may be abbreviated as "sweetener (a)” or “ingredient (a)" means a compound having a stronger sweetness than sucrose, and is a naturally derived compound. , Synthetic compounds or combinations of naturally occurring compounds and synthetic compounds. High sweetness sweetener is 5 times or more, 10 times or more, 50 times or more, 100 times or more, 500 times or more, 1,000 times or more, 5,000 times or more, 10,000 times or more, 50,000 times in the same amount as sucrose. It has a sweetness of 100,000 times or more.
- high-sweetness sweeteners include peptide-based sweeteners such as aspartame, neotheme, and advanced, and sucrose derivatives such as sucralose, such as acesurfam K, saccharin, sodium saccharin, sodium cyclamate, zultin, and diglycyrrhizinate.
- Synthetic sweeteners such as sodium, trisodium glycyrrhizinate, neohesperidin dihydrochalcone (including naturally occurring but predominantly synthetic products such as neohesperidin dihydrocarcon), such as somatin and monerin.
- Thunberg Extracts Thaumataococcus daniellii Benth extract, Dioscoreophyllum volkensii extract, Curculigo latifolia extract, Richadella dulcifica extract, Richadella dulcifica extract, Pentadiplandra Masaikai extract, Lippia dulcis (sweet herb Mexican) extract, etc. and sweeteners in the extract, such as stevia extract and stevia derivative such as enzyme-treated stevia, which is obtained by enzymatically treating stevia and adding glucose.
- Glycyrrhiza glabra Plant-containing sweeteners eg, triterpene such as glycyrrhizin
- sugars obtained from plant extracts such as steviol sugar, mogloside obtained by processing Luo Han Guo and Luo Han Guo extract.
- Sugar steviol sugar
- mogloside obtained by processing Luo Han Guo and Luo Han Guo extract.
- Plant-containing sweet components eg, diterpen sugars such as rubusoside
- Hydrorangea macrophylla var eg, diterpen sugars such as rubusoside
- Thunbergii Plant-containing sweet components eg, dihydroisocoumarin such as phyllozlutin
- Sclerochiton ilicifolius Plant-containing sweet components eg, amino acids such as monatin
- Thaumataococcus daniellii Benth plant-containing sweet components eg, proteins such as somatin
- Dioscoreophyllum volkensii plant-containing sweet components eg, proteins such as monerin
- Curculigo latifolia plant-containing sweet components eg, proteins such as curculin
- Richadella dulcifica Plant-containing sweet components eg, proteins such as miraculin
- Pentadiplandra brazzeana Plant-containing sweet components eg, proteins such as brazein and pentadin
- Capparis masaikai Plant-containing sweet components eg, proteins such as mabinlin
- Lippia dulcis Plant-containing sweet components Ingredients (eg, sesquitelpen such as her
- Steviol glycosides include rebaugioside A (hereinafter, “rebaugioside” may be abbreviated as “Reb”), RebB, RebC, RebD, RebE, RebF, RebI, RebJ, RebK, RebM, RebN, RebO, RebQ, Examples thereof include RebR, Zulcoside A, Zulcoside C, Rubusoside, Steviol, Steviol Monoside, Steviolbioside and Stevioside.
- mogroside include mogroside IV (hereinafter, “mogroside” may be abbreviated as "Mog”), MogV and the like.
- the licorice (licorice) extract is obtained from the roots or rhizomes of Glycyrrhiza uralensis, Glycyrrhiza chinensis or Glycyrrhiza vulgaris, and is mainly composed of glycyrrhizic acid.
- licorice extract include licorice extract, glycyrrhizin, and licorice extract.
- the sucrose derivative includes, for example, one obtained by substituting the OH group or H group of sucrose with another substituent, and examples thereof include a halogen derivative (sucralose) of sucrose and an oxathiadinone dioxide derivative. And so on.
- the high sweetness sweetener is selected from the good quality high sweetness sweeteners.
- “good taste, high sweetness sweetener” has (1) less astringent taste, (2) less metallic taste, (3) less sweetness aftertaste, and (4). It means a high-sweetness sweetening substance having one or more taste characteristics selected from those having less bitterness. Whether or not a certain sweet substance has the above-mentioned taste characteristics is known or can be determined based on a sensory evaluation or the like.
- Non-limiting examples of good-tasting, high-sweetness sweeteners include, for example, RebD, RebM, neohesperidin dihydrocalcone, glycyrrhizin, somatin, monerin, mogroside, rubsoside, curculin, mabinlin, brazein, pentazine, phylloslutin, hernanzultin. , Miraclen, Stevia rebaudiana plant-containing sweet ingredient, Siraitia grosvenorii plant-containing sweet ingredient, Glycyrrhiza glabra plant-containing sweet ingredient, Rubus suavissimus S. Lee plant-containing sweet ingredient, Hydrona macrophylla var.
- Thunbergii plant-containing sweet ingredient Plant-containing sweetness ingredient
- Thaumataococcus daniellii Benth Plant-containing sweetening ingredient Dioscoreophyllum volkensii Plant-containing sweetening ingredient
- Curculigo latifolia Plant-containing sweetening ingredient Richardella dulcifica Plant-containing sweetening ingredient
- Pentadiplandra brazzeana Plant-containing sweetening ingredient Capparismasai Examples thereof include plant-containing sweet components, derivatives thereof, and combinations thereof.
- Good-quality, high-sweetness sweeteners do not contain the main components of stevia sweeteners such as RebA and stevioside.
- the good taste, high sweetness sweetener comprises RebD, RebM, mogroside (eg, MogV), thaumatin, brazzein or a combination thereof.
- the good taste, high sweetness sweetener comprises RebD, RebM, mogroside (eg, MogV), thaumatin or a combination thereof.
- the good-tasting, high-sweetness sweetener comprises RebD, RebM, MogV, Luo Han Guo extract and combinations thereof.
- the high sweetness sweetener may be naturally occurring in plants or the like, or may be artificially produced (eg, by bioconversion, chemical synthesis, etc.). Good, but preferably a naturally occurring sweetener.
- naturally occurring does not mean that the high-sweetness sweetening substance contained in the oral composition of the present invention is a natural substance, as long as the same substance is naturally present.
- the high-sweetness sweetening substance contained in the oral composition of the present invention may be artificially produced (for example, by bioconversion or the like) (non-natural substance).
- Non-limiting examples of the sweetener (a) include, for example, RebA, RebD, RebM, neohesperidin dihydrochalcone, glycyrrhizin, somatin, monerin, mogroside, rubusoside, curculin, mabinlin, brazein, pentazine, phylloslutin, hernanzultin, Miraclen, Stevia rebaudiana plant-containing sweetening ingredient, Siraitia grosvenorii plant-containing sweetening ingredient, Glycyrrhiza glabra plant-containing sweetening ingredient, Rubus suavissimus S. Lee plant-containing sweetening ingredient, Hydrorangea macrophylla var.
- the sweetener (a) comprises RebA, RebD, RebM, mogroside (eg, MogV) or a combination thereof.
- the sweetener (a) comprises RebA, RebD, RebM, mogroside (eg, MogV), thaumatin or a combination thereof.
- the high sweetness sweetener comprises at least one selected from the group consisting of RebA, RebD, RebM, MogV, Luo Han Guo extract and combinations thereof.
- the sweetener (a) is substantially composed of sweeteners other than the major components of stevia sweeteners such as RebA and stevioside.
- “substantially from” means that the sweetener used in the present invention may contain the main components of the stevia sweetener as long as the effects of the present invention are not impaired.
- the sweeteners (a) used in the present invention preferably 90% or more, more preferably 95% or more, still more preferably 98% or more consist of sweeteners other than RebA and stevioside.
- RebA, RebD and RebM may be extracted directly from Stevia, or may be obtained by adding glucose to a compound having another structure contained in the Stevia extract.
- Luo Han Guo extract as a sweetener is an extract of Luo Han Guo containing a sweetening substance derived from Luo Han Guo, and is approved as a food additive in various countries including Japan and is commercially available.
- sweetening substance derived from Luo Han Guo include MogV, MogIV, 11-oxo-mogroside V, and siamenoside I.
- MogV is one of the major mogrol glycosides contained in Luo Han Guo, and it has been reported that it exhibits high-quality sweetness characteristics similar to sucrose compared to RebA.
- MogV can be obtained by purifying from Luo Han Guo extract (for example, alcohol extract of Luo Han Guo) by chromatography or the like. Alternatively, MogV may be obtained by adding glucose to a compound having another structure contained in the Luo Han Guo extract.
- the Rakan fruit extract preferably contains MogV, the proportion of which is not limited, but is 10% by weight or more, 15% by weight or more, 20% by weight or more, 25% by weight or more, 30% by weight of the total dry weight of the Rakan fruit extract. % Or more, 35% by weight or more, 40% by weight or more, 45% by weight or more, 50% by weight or more, 55% by weight or more, 60% by weight or more, 65% by weight or more, 70% by weight or more or 75% by weight or more. It's okay.
- the content of MogV can be determined by a known method, such as liquid chromatography.
- the fruit of Rakan fruit (Siraitia grosvenorii) is used as an appropriate solvent (for example, an aqueous solvent such as water, an alcohol solvent such as ethanol and methanol, a mixed solvent of an aqueous solvent such as hydrous ethanol and water-containing methanol, and an alcohol solvent. Etc.), and then optionally subjected to treatments such as degreasing, purification, concentration, and drying.
- an appropriate solvent for example, an aqueous solvent such as water, an alcohol solvent such as ethanol and methanol, a mixed solvent of an aqueous solvent such as hydrous ethanol and water-containing methanol, and an alcohol solvent. Etc.
- MogV may be of high purity, for example, purity of 80% or more, 85% or more, 90% or more, 91% or more, 92% or more, 93% or more, 94% or more, 95% or more, 96%. As mentioned above, it may be 97% or more or 98% or more. As a matter of course, the higher the purity of MogV obtained by purifying the Luo Han Guo extract, the smaller the amount of the Luo Han Guo extract components other than MogV mixed in.
- MogV may be of lower purity, eg, 50% or more, 55% or more, 60% or more, 65% or more, 70% or more or 75% or more. It may be a thing.
- the sweetness intensity of sucrose per unit concentration Brix 1 is defined as the sweetness degree 1
- the calculated value of the sweetness degree of MogV having a purity of about 65% is about 175.
- Luo Han Guo extract containing about 30% by weight of MogV may be used as a high-sweetness sweetener, and the sweetness intensity exhibited by sucrose per unit concentration Brix 1 is defined as sweetness 1. In this case, the calculated sweetness of this Luo Han Guo extract is about 100.
- the high sweetness sweetener is contained in an amount equivalent to the sweetness intensity X1 as described above.
- sweetness intensity of sucrose per unit concentration Brix 1 is defined as sweetness 1
- RebD has a sweetness of about 225
- RebM has a sweetness of about 230
- RebB has a sweetness of about 325
- RebA has a sweetness of 200.
- ⁇ 300 center value 250
- RebN sweetness 200-250 center value 225
- RebO sweetness 200-250 center value 225
- RebE sweetness 70-80 center value 75
- the sweetness of Rakan fruit extract (containing 40% MogV) is about 130
- the sweetness of MogV is about 270
- the sweetness of somatin is 2,000
- the sweetness of brazein is 500 to 2000 (center value 1250).
- the value obtained by multiplying these sweetnesses by the concentration of the high-sweetness sweetener in the oral composition is the value of the high-sweetness sweetener. It becomes sweetness intensity.
- w / v% which can be equated with w / w% in the case of beverages
- the relative ratio of the sweetness of various sweeteners to the sweetness of sucrose 1 can be obtained from a known sugar sweetness conversion table (for example, Beverage Japan Co., Ltd. "Beverage Glossary", page 11).
- the median value is used for those whose sweetness is shown in the numerical range.
- the relative ratio of sweetness to sweetness 1 of sucrose can be determined by a sensory test.
- a sensory test for example, a sample in which sucrose is added to pure water from Brix 3.0 to 5.0 in 0.5 increments is prepared, and the sweetness intensity equivalent to that of an aqueous solution of a sweetener having a predetermined concentration is obtained from the sample.
- the high-intensity sweetener is derived from steviol glycoside, Luo Han Guo extract, mogrol glycoside, Thaumataococcus daniellii Benth plant-containing sweetener, Pentadiplandra brazzeana plant-containing sweetener, artificial sweetener and combinations thereof.
- the high sweetness sweeteners are RebA, RebB, RebC, RebD, RebE, RebF, RebI, RebJ, RebK, RebM, RebN, RebO, RebQ, RebR, Zulcoside A, Zulcoside C, Rubusoside, Includes at least one selected from the group consisting of steviol monoside, steviol bioside, stevioside, Rakan fruit extract, MogV, thaumatin, brazzein, aspartame, acesulfam K, sucralose, kanzo extract, saccharin, and combinations thereof.
- the sweetener (a) comprises the following combinations: RebA and RebM, RebA and RebD, RebD and RebM, RebA and RebD and RebM, RebA and MogV, RebD and MogV, RebM and MogV, RebA.
- RebM and MogV RebA and RebD and MogV, RebD and RebM and MogV, RebA and neohesperidin dihydrocalcon, RebD and neohesperidin dihydrocalcon, RebM and neohesperidin dihydrocalcon, RebA and RebM and neohesperidin dihydrocalcon, RebA and RebD Neohesperidin dihydrocalcon, RebD and RebM and neohesperidin dihydrocalcon, MogV and neohesperidin dihydrocalcon, RebD and RebM and MogV and neohesperidin dihydrocalcon, RebA and brazein, RebM and brazein, MogV and brazein, neohesperidin Dihydrocalcon and brazein, RebM and RebD and brazein, RebM and RebD and brazein and MogV, RebM and RebD and brazein and MogV, Reb
- the sweetener (a) comprises the following combinations: RebA and thaumatin, RebD and thaumatin, RebM and thaumatin, MogV and thaumatin, RebA and RebM and thaumatin, RebA and RebD and thaumatin, RebD and RebM and thaumatin. , RebA and MogV and thaumatin, RebD and MogV and thaumatin, RebM and MogV and thaumatin, RebD and RebM and MogV and thaumatin.
- the sweetener (a) is selected from a high sweetness sweetener selected from RebA, RebD, RebM, MogV, Luo Han Guo extract and combinations thereof, preferably from RebD, RebM and combinations thereof. May contain one or more high-sweetness sweeteners.
- the amount of the sweetener (a) contained in the oral composition in one aspect of the present invention is an amount obtained by combining all the sweeteners.
- the amount of sweetener (a) is Pa (ppm)
- Pa is, for example, about 20 to about 800, about 25 to about 800, about 30 to about 800, about 35 to about 800, about 40 to about 800, About 45 to about 800, about 50 to about 800, about 55 to about 800, about 20 to about 750, about 25 to about 750, about 30 to about 750, about 35 to about 750, about 40 to about 750, about 45 ⁇ 750 ⁇ 50 ⁇ 750, 55 ⁇ 750, about 20 ⁇ 700, about 25 ⁇ 700, about 30 ⁇ 700, about 35 ⁇ 700, about 40 ⁇ 700, about 45 ⁇ about 700, about 50 to about 700, about 55 to about 700, about 20 to about 650, about 25 to about 650, about 30 to about 650, about 35 to
- the amount of high sweetness sweetener Pappm is about 20 to about 600 ppm, about 30 to about 550 ppm, about 55 to about 490 ppm, about 20 to about 200 ppm, about 100 to about 500 ppm or about 150. It may be up to about 350 ppm.
- the phospholipid used in the present invention is an amphoteric lipid having a phosphorus atom in its structure in the form of a phosphate ester.
- Phospholipids include glycerophospholipids having glycerin as a skeleton and sphingolipids having sphingosine as a skeleton.
- Glycerophospholipids typically have a structure in which fatty acids are ester-bonded to the 1st and 2nd positions of glycerin and phosphoric acid is ester-bonded to the 3rd position, and alcohols such as choline, ethanolamine, serine, and inositol are ester-bonded to the phosphate group. ..
- glycerophospholipids include, for example, phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylinositol (PI), phosphatidylserine (PS), phosphatidylglycerol (PG), cardiolipin and the like.
- Non-limiting examples of sphingolipids include, for example, sphingomyelin (SM) and the like.
- SM sphingomyelin
- two fatty acids are bound to the basic skeleton such as glycerin and sphingosine, but phospholipids to which only one fatty acid is bound are called lysophospholipids.
- Non-limiting examples of lysophospholipids include lysophosphatidylcholine (LPC), lysophosphatidylethanolamine (LPE), lysophosphatidylinositol (LPI), lysophosphatidylserine (LPS), lysophosphatidylglycerol (LPG) and other lysoglycerophospholipids.
- LPC lysophosphatidylcholine
- LPE lysophosphatidylethanolamine
- LPI lysophosphatidylinositol
- LPS lysophosphatidylserine
- LPG lysophosphatidylglycerol
- lysoglycerophospholipids include lysosphingolipids such as sphingomyelin (LSM).
- LSM sphingomyelin
- the lysoglycerophospholipid has a
- the phospholipid comprises a zwitterionic phospholipid.
- Zwitterionic phospholipids are lipids that have both positive and negative charges within the molecule.
- Non-limiting examples of zwitterionic phospholipids include PC, PE, LPC, LPE and the like.
- the phospholipid comprises a zwitterionic lysophospholipid (eg, LPC, LPE).
- the fatty acid contained in the phospholipid may be a saturated fatty acid or an unsaturated fatty acid.
- a phospholipid containing two fatty acids for example, glycerophospholipid, may have a saturated fatty acid at the 1st position and an unsaturated fatty acid at the 2nd position, or an unsaturated fatty acid at the 1st position and a saturated fatty acid at the 2nd position.
- both may be saturated fatty acids or both may be unsaturated fatty acids.
- the fatty acid may have various lengths, and the number of carbon atoms contained in the fatty acid is not limited, for example, 8 or more, 10 or more, 12 or more, 14 or more, 15 or more, 16 or more, 8 to 30, 10 to 28.
- the phospholipid containing two fatty acids may contain any combination of the above carbon number fatty acids.
- the carbon number contained in the fatty acid is 14, 15, 16, 17, 18, 20, 22 or 23.
- the combination of carbon atoms of the fatty acid is (14,18), (16,16), (15,18), (16,18), (17,18), It is selected from (18, 18), (18, 20), (18, 22) and (18, 23).
- the molecular species of fatty acids contained in phospholipids are (14: 0), (15: 0), (16: 0), (16: 1), (17: 0), (17: 1). , (18: 0), (18: 1), (18: 2), (18: 3), (20: 0), (20: 1), (22: 0) and (23: 0) Will be done.
- the number before the colon in parentheses indicates the number of carbon atoms of the fatty acid
- the number after the colon indicates the number of double bonds of the fatty acid.
- (16: 1) indicates a 16-carbon fatty acid containing one double bond.
- the combination of fatty acid molecular species contained in a phospholipid containing two fatty acids is (14: 0, 18: 2), (14: 0, 18: 1), (16: 0, 16: 0). ), (15: 0, 18: 2), (16: 1, 18: 2), (16: 0, 18: 2), (16: 0, 18: 1), (17: 1, 18: 2) ), (17: 0, 18: 1), (18: 3, 18: 3), (18: 2, 18: 3), (18: 2, 18: 2), (18: 1, 18: 2) ), (18: 1, 18: 1), (18: 2, 20: 1), (18: 2, 20: 0), (18: 2, 22: 0) and (18: 2, 23: 0) ) Is selected.
- the phospholipids are LPC (14: 0), 2-LPC (16: 0), 1-LPC (16: 0), LPC (17: 0), 2-LPC (18: 3), 1-LPC (18: 3), LPC (18: 2), 2-LPC (18: 1), 1-LPC (18: 1), LPC (18: 0), LPC (20: 0), LPC ( 22: 0), PC (14: 0, 18: 2), PC (14: 0, 18: 1), PC (16: 0, 16: 0), PC (15: 0, 18: 2), PC (16: 1, 18: 2), PC (16: 0, 18: 2), PC (16: 0, 18: 1), PC (17: 1, 18: 2), PC (17: 0, 18) 1), PC (18: 3, 18: 3), PC (18: 2, 18: 3), PC (18: 2, 18: 2), PC (18: 1, 18: 2), PC ( 18: 1, 18: 1), PC (18: 2, 20: 1), PC (18: 2, 20: 0), PC (18: 2, 22: 0) and PC (18: 2, 23 :) It is selected from 0
- LPC is lysophosphatidylcholine
- 1-LPC is lysophosphatidylcholine in which a fatty acid is bound to the 1st position of glycerin
- 2-LPC is a fatty acid bound to the 2nd position of glycerin.
- Lysophosphatidylcholine and PC represent phosphatidylcholine, respectively.
- Phospholipids may be purified from living organisms.
- the phospholipid can be derived from plants such as soybean, rapeseed, sunflower, abra palm, sesame, corn, peanut, olive, cotton, flax (particularly oil-containing plants), egg yolk and the like.
- the phospholipids are derived from plants selected from soybeans, rapeseed, sunflowers and oil palms.
- Phospholipids may be obtained by purification from living organisms or commercially available products may be used. Purification of phospholipids can be performed using any known method. Typically, phospholipids can be obtained by exploiting oils from raw materials, adding warm water to the oils to hydrate phospholipids, recovering gums, drying and filtering them. Commercially available products include Riken Vitamin Co., Ltd.'s Resion (R) P, Resion ( R) LP-1, Resimal (R) EL, Tsuji Oil Co., Ltd.'s SLP-Paste, SLP-White, SLP-PC35, SLP.
- Phospholipid products for food are preferred. Products containing phospholipids may be referred to as lecithin.
- the oral composition of the present invention may contain one or more phospholipids.
- the oral composition of the present invention may contain, for example, a mixture of two or more of the above phospholipids.
- Phospholipids purified from living organisms often contain multiple molecular species.
- the phospholipid comprises a combination of molecular species selected from Table 2 below.
- Intrinsic phospholipids refer to phospholipids that are included as an ingredient unique to oral compositions.
- the unique phospholipids may be derived from the raw materials constituting the oral composition or from the additives usually used depending on the type of the oral composition.
- Non-limiting examples of the former include, for example, phospholipids derived from coffee beans in coffee beverages, phospholipids derived from soybeans in soybean milk beverages, phospholipids derived from milk in dairy beverages, and the like. Examples thereof include phospholipids contained as an emulsifier in ice cream, margarine, confectionery, prepared milk powder and the like.
- the oral composition of the present invention comprises (c) a heterologous phospholipid below the taste cognitive threshold.
- Heterologous phospholipids refer to different types of phospholipids than endemic phospholipids. It can also be said that the heterologous phospholipid is a phospholipid other than the unique phospholipid. What is different from the unique phospholipid? For example, if there is only one unique phospholipid, the heterologous phospholipid can be any phospholipid (one or a combination of multiple types) other than the unique phospholipid. could be.
- the heterologous phospholipid may be a phospholipid not contained in the unique phospholipid or a combination of phospholipids containing the phospholipid.
- the unique phospholipid consists of a combination of phospholipids A and B
- the heterologous phospholipid is a phospholipid C different from phospholipids A and B, or a combination of phospholipid C with any other phospholipid.
- It may be a combination of phospholipids containing phospholipids A and / or B as long as it contains phospholipid C).
- the type different from the unique phospholipid may be, for example, a phospholipid derived from a material different from the material from which the unique phospholipid is derived (for example, organism, foodstuff, etc.).
- the heterologous phospholipids are phospholipids other than phospholipids derived from coffee beans (eg, soybean, rapeseed, sunflower, abra palm, sesame, etc. Phospholipids derived from corn, coffee, olives, cotton, flax, egg yolk, milk, etc.), and if the soybean milk beverage contains only soybean-derived phospholipids, the heterologous phospholipids are other than soybean-derived phospholipids.
- Phospholipids eg, phospholipids derived from rapeseed, sunflower, abra palm, sesame, corn, soybean, olive, cotton, flax, coffee, egg yolk, milk, etc.
- the milk beverage contains only phospholipids derived from milk.
- Is a heterologous phospholipid other than phospholipids derived from milk eg, phospholipids derived from soybean, rapeseed, sunflower, abra palm, sesame, corn, lacquer, olive, cotton, flax, coffee, egg yolk, etc.
- Unique phospholipids and heterologous phospholipids can be distinguished by the presence of unique molecular species, combinations of unique molecular species, and the like.
- coffee-derived phospholipids are soybeans due to the presence of 2-LPC (18: 2), 1-LPC (18: 2) or PC (18: 0, 18: 3).
- Phospholipids derived from rapeseed, sunflower and milk, and phospholipids derived from soybean should be distinguished from phospholipids derived from rapeseed, sunflower, coffee and milk by the presence of 2-LPC (18: 3).
- the milk-derived phospholipids are C10: 0 fatty acid, LPC (14: 0), LPC (16: 0), LPC (18: 1), PC (14: 0, 16: 0), PC (14). 1, 18: 2), PC (15: 0, 16: 0), PC (15: 0, 18: 0), PC (16: 0, 18: 0) or PC (18: 0, 18: 1) )
- LPC 14: 0
- LPC 16: 0
- LPC LPC (18: 1)
- PC (14: 0, 16: 0), PC (14). 1, 18: 2) PC (15: 0, 16: 0), PC (15: 0, 18: 0), PC (16: 0, 18: 0) or PC (18: 0, 18: 1)
- the molecular species of phospholipids are not limited, and can be specified by, for example, LC-MS.
- the taste threshold value of phospholipids, high-sweetness sweeteners, and the like means a taste detection threshold value or a taste recognition threshold value.
- the taste detection threshold is a minimum concentration that can clearly indicate the difference from water, but does not necessarily have to be able to recognize the type of taste (eg, bitterness, acidity, sweetness, etc.).
- the taste cognitive threshold means the minimum concentration at which the taste can be recognized (for example, Eur J Clin Nutr (2004) 58, 629-636).
- the taste recognition threshold is about 1.5 to 2 times the taste detection threshold (Yuki Yamauchi et al., "Whole Oral Taste Test (1st Report) -Basic Study and Main Principle Analysis-", Japan Otolaryngology Society Bulletin Vol. 98 (1995) No. 1, p.119-129, and Reiko Omori, "Comparison of Taste Sensitivity Between Generations", Utsunomiya University Faculty of Education Bulletin, Part 1 (2013) Vol.63 p .201-210)).
- the taste recognition threshold value of a substance can be obtained by a sensory test in which an aqueous solution containing the substance is prepared at a plurality of concentration levels, tasted in order from the one with the lowest concentration to the one with the highest concentration, and whether or not the taste is felt.
- the concentration at which it is detected to be different from water is defined as the taste detection threshold
- the concentration at which taste is recognized is defined as the taste recognition threshold.
- a substance that already has a theoretical value (literature value)
- it can be determined by preparing aqueous solutions having a plurality of concentration levels near the concentration and testing by a plurality of persons trained in sensory.
- the taste recognition threshold means the taste recognition threshold in pure water.
- the taste recognition threshold in pure water is, for example, in the case of phospholipids in the oral composition of the present invention, the minimum amount at which the taste can be recognized when only phospholipids are added to water without adding a sweetener or the like. It means the concentration of the limit.
- the taste recognition threshold of phospholipids may vary depending on the species of organism from which they are derived, the combination of molecular species contained therein, etc., but is typically about 10 to about 250 ⁇ g / mL, and aqueous solutions with multiple concentration levels are prepared within this range. By doing so, the sensory test can be performed efficiently.
- the concentration of the heterologous phospholipid contained in the oral composition of the present invention is not limited, for example, less than about 250 ⁇ g / mL, less than about 240 ⁇ g / mL, less than about 230 ⁇ g / mL, less than about 220 ⁇ g / mL, about 210 ⁇ g /.
- the concentration of heterologous phospholipids contained in the oral composition of the invention is not limited, for example, from about 1.6125 to about 12.5 ⁇ g / mL, from about 3.125 to about 12.5 ⁇ g / mL, from about 3.125 to about 25 ⁇ g. / mL, about 6.25 to about 25 ⁇ g / mL, about 6.25 to about 50 ⁇ g / mL, about 12.5 to about 25 ⁇ g / mL, about 25 to about 50 ⁇ g / mL, about 100 to about 150 ⁇ g / mL or about 100 to about 200 ⁇ g / mL May be.
- sweetener The oral composition of the present invention may contain a sweetener in addition to the high sweetness sweetener of the component (a).
- sweetener means any substance or group of substances that causes a sweetening response.
- the sweeteners can be divided into sugar-based sweeteners and non-sugar-based sweeteners according to their structural characteristics, and low-sweetness sweeteners and high-sweetness sweeteners based on the degree of sweetness. Further, based on energy (calories), sweeteners can be divided into caloric sweeteners and non-caloric sweeteners. Furthermore, it can be divided into natural sweeteners and artificial sweeteners based on the acquisition method.
- Carbohydrate-based sweeteners are not limited to starch sugars such as sucrose, lactose, glucose, malt sugar, water candy, high fructose corn syrup, and fructose, and sugar alcohols such as erythritol, sorbitol, mannitol, martitol, xylitol, and palatinit. , Palatinose, fructose oligosaccharide, coupling sugar (R) , galactooligosaccharide, milk fruit oligosaccharide, raffinose, soybean oligosaccharide, honey and the like.
- the sugar-based sweetener contains a rare sugar.
- Rare sugar refers to monosaccharides and their derivatives whose abundance is small in nature. For example, naturally occurring aldoses other than D-glucose, D-galactose, D-mannose, D-ribose, D-xylose and L-arabinose, naturally occurring ketose other than D-fluctose, and natural other than D-sorbitol.
- the sugar alcohols and the like present in the rare sugars are included in the rare sugars.
- Non-limiting examples of rare sugars include, for example, D-tagatose, D-sorbose, D-alloth (D-psicose), L-fluctose, L-allulose (L-psicose), L-tagatose, L-sorbose, etc.
- Examples thereof include aldose such as ketose, altrose and D-allose, and sugar alcohols such as xylitol, erythritol and D-talitol.
- Caloric sweeteners typically mean sweeteners with an energy of 4 kcal / g. Whether the energy of the sweet substance is known, the content is measured by HPLC etc. and calculated by multiplying by the energy conversion coefficient, or the physical combustion heat is measured by a calorimeter (for example, bomb calorimeter etc.). Can be determined by correcting the digestion and absorption rate, the amount of heat excreted, and the like.
- caloric sweeteners include, for example, sucrose, lactose, glucose, maltose, starch syrup, high fructose corn syrup, fructose and the like.
- Non-caloric sweeteners typically refer to those that are difficult to digest in the body and result in less energy being taken in, less than 2 kcal / g, preferably less than 1 kcal / g, more preferably. It means a sweetening substance having an energy of less than 0.5 kcal / g.
- Non-caloric examples of non-caloric sweeteners include, for example, non-caloric hexoses such as allose (psicose) and allose, non-caloric pentoses such as xylose and arabinose, non-caloric tetrose such as erythrose and treose, erythritol and aritol.
- Non-caloric sugar alcohols and the like can be mentioned.
- sweet substances can be classified by energy (calorie) level.
- sweet substances can be classified into sweet substances having an energy of 4 kcal / g or more and sweet substances having an energy of less than 4 kcal / g.
- Sweet substances with energy less than 4 kcal / g are further sweet substances with energy less than 3 kcal / g, sweet substances with energy less than 2.5 kcal / g, sweet substances with energy less than 2 kcal / g, 1.5 kcal / Sweet substance with energy less than g, sweet substance with energy less than 1 kcal / g, sweet substance with energy less than 0.5 kcal / g, sweet substance with energy more than 1 kcal / g and less than 4 kcal / g, 2 kcal / Sweet substance with energy of g or more and less than 4 kcal / g, sweet substance with energy of 3 kcal / g or more and less than 4 kcal / g, sweet substance with energy of 2 kcal /
- Sucrose, lactose, glucose, malt sugar, water candy, isomerized sugar, fructose, etc. are sweet substances having an energy of 4 kcal / g or more, and sorbitol is a sweet substance having an energy of 2 kcal / g or more and less than 4 kcal / g. , Xylose, D-xylose, D-ribose, D-tagatose, arabinose, etc.
- sweet substances having an energy of 0 kcal / g or more and less than 2 kcal / g, such as D-allulose, erythritol, allose, erythreose, threose, and aritol. And so on.
- a low-sweetness sweetener means a compound having a sweetness similar to that of sucrose (for example, less than 5 times, 0.1 to 2 times, 0.5 to 1.5 times, etc. of sucrose).
- Non-limiting examples of low-sweetness sweeteners include sucrose, high fructose corn syrup, glucose, fructose, lactose, malt sugar, xylose, lactulose, fructo-oligosaccharide, maltooligosaccharide, isomaltooligosaccharide, galactooligosaccharide, and coupling sugar (R).
- low-sweetness sweeteners include rare sugars, caloric sweeteners, non-caloric sweeteners, sugar-based sweeteners, non-sugar-based sweeteners, natural sweeteners, and so on, as long as the sweetness is within the above range. Contains artificial sweeteners.
- the oral composition in one embodiment of the present invention comprises a low sweetness sweetener.
- the following oral composition (hereinafter, also referred to as the oral composition of aspect A) is provided.
- (d) Low sweetness sweetener in an amount equivalent to sweetness intensity X4 In this specification, it may be abbreviated as "component (d)”.
- component (d) Including An oral composition having a sweetness intensity of X2 due to the components (a) and (b) and a sweetness of a sweetness intensity of X5 due to the components (a) to (d), 0.1 ⁇ X2 + X4 ⁇ X5.
- the oral composition according to one embodiment of the present invention contains, as a sweetener, (a) a high-sweetness sweetener in an amount equivalent to a sweetness intensity X1 and (d) an ingredient other than a low-sweetness sweetener in an amount equivalent to a sweetness intensity X4. do not have.
- the low sweetness sweetener includes a sweetener selected from hexose, pentose, tetrose, a polysaccharide having an aldose or ketose terminal sugar, a sugar alcohol, and a combination thereof.
- the low sweetness sweetener is a sweetener selected from glucose, sucrose, fructose, maltose, oligosaccharides, high fructose corn syrup, lactose, psicose, allose, tagatose, xylose, ribose and combinations thereof. Including charges.
- the low sweetness sweetener comprises a sweetener selected from glucose, sucrose, fructose and combinations thereof.
- X4 of "sweetness intensity X4" is 0 to 0.5, 0 to 1.0, 0 to 1.5, 0 to 2.0, 0 to 2.5, 0 to 3.0, 0 to 3.5, 0 to 4.0, 0 to 4.5, 0 to 5.0, 0 to 5.5, 0-6.0, 0-6.5, 0-7.0, 0-7.5, 0-8.0, 0-8.25, 0-8.5, 0-8.75, 0-9.0, 0-9.25, 0-9.5, 0-9.75, 0 to 10.0, 0.05 to 0.5, 0.05 to 1.0, 0.05 to 1.5, 0.05 to 2.0, 0.05 to 2.5, 0.05 to 3.0, 0.05 to 3.5, 0.05 to 4.0, 0.05 to 4.5, 0.05 to 5.0, 0.05 to 5.5, 0.05 to 6.0, 0.05-6.5, 0.05-7.0, 0.05-7.5, 0.05-8.0, 0.05-8.25, 0.05-8.5, 0.05-8.75, 0.05-9.0, 0.05-9.25,
- X4 is also 0 to 10.5, 0 to 11.0, 0 to 11.5, 0 to 12.0, 0 to 12.5, 0 to 13.0, 0 to 13.5, 0 to 14.0, 0 to 14.5, 0 to 15.0, 0.05 to 10.5, 0.05 to 11.0, 0.05-11.5, 0.05-12.0, 0.05-12.5, 0.05-13.0, 0.05-13.5, 0.05-14.0, 0.05-14.5, 0.05-15.0, 0.1-10.5, 0.1-11.0, 0.1-11.5, 0.1-12.0, 0.1 to 12.5, 0.1 to 13.0, 0.1 to 13.5, 0.1 to 14.0, 0.1 to 14.5, 0.1 to 15.0, 0.5 to 10.5, 0.5 to 11.0, 0.5 to 11.5, 0.5 to 12.0, 0.5 to 12.5, 0.5 to 13.0, 0.5 to 13.5, 0.5-14.0, 0.5-14.5, 0.5-15.0, 1.0-10.5, 1.0-11.0, 1.0-11.5, 1.0-12.0, 1.0-12.5, 1.0-13.0, 1.0
- the amount equivalent to the sweetness intensity X4 of the low sweetness sweetener is the amount (concentration) that exhibits the sweetness of the low sweetness intensity X4 under the condition that the low sweetness sweetener is dissolved in water at 20 ° C. having the same volume as the oral composition of the present invention. ).
- X5 is not particularly limited as long as it is larger than X2 + X4, but 4.0 to 20, 4.0 to 15, 4.0 to 12.5, 4.0 to 10, 4.5 to 20, 4.5 to 15, 4.5 to 12.5, 4.5 to 10, 5.0 to 20 , 5.0 ⁇ 15, 5.0 ⁇ 12.5, 5.0 ⁇ 10, 5.5 ⁇ 20, 5.5 ⁇ 15, 5.5 ⁇ 12.5, 5.5 ⁇ 10, 6.0 ⁇ 20, 6.0 ⁇ 15, 6.0 ⁇ 12.5, 6.0 ⁇ 10, 6.5 ⁇ 20, 6.5 ⁇ 15, 6.5 ⁇ 12.5, 6.5 ⁇ 10, 7.0 ⁇ 20, 7.0 ⁇ 15, 7.0 ⁇ 12.5, 7.0 ⁇ 10, 7.5 ⁇ 20, 7.5 ⁇ 15, 7.5 ⁇ 12.5, 7.5 ⁇ 10, 7.5 ⁇ 9, 7.5 ⁇ 8 , 8.0-20, 8.0-20, 8.0-15, 8.0-12.5, 8.0-10, 8.5-20, 8.5-15, 8.5-12.5, 8.5-10, 9.0-20, 9.0-15, 9.0-12.5, 9.0 It may be ⁇ 10,
- X5 is also 4.0-18, 4.0-16, 4.0-15.5, 4.0-14, 4.5-18, 4.5-16, 4.5-15.5, 4.5-14, 5.0-18, 5.0-16, 5.0-15.5, 5.0- 14, 5.5-18, 5.5-16, 5.5-15.5, 5.5-14, 6.0-18, 6.0-16, 6.0-15.5, 6.0-14, 6.5-18, 6.5-16, 6.5-15.5, 6.5-14, 7.0-18, 7.0-16, 7.0-15.5, 7.0-14, 7.5-18, 7.5-16, 7.5-15.5, 7.5-14, 7.5-9, 7.5-8, 8.0-18, 8.0-18, 8.0- 16, 8.0-15.5, 8.0-14, 8.5-18, 8.5-16, 8.5-15.5, 8.5-14, 9.0-18, 9.0-16, 9.0-15.5, 9.0-14, 9.5-18, 9.5-16, It may be 9.5 to 15.5, 9.5 to 14, 10.0 to 18, 10.0 to 16, 10.0 to 15.5, 10.5 to 18, 10.5 to 16 or 10.5 to 15.5.
- the oral composition of the present invention comprises an antioxidant (sodium erythorsorbate, etc.), an emulsifier (sucrose fatty acid ester, sorbitan fatty acid ester, polyglycerin fatty acid ester, etc.), and an acidulant (phosphoric acid, etc.) as long as the effects of the present invention are not impaired. Acids, citric acid, malic acid, etc.), fragrances, etc. can be appropriately blended.
- the oral composition of the invention is substantially free of sodium. Substantially free means, for example, that sodium is not detected (ie, below the detection limit) in the oral composition. Sodium can be detected by, for example, atomic absorption spectroscopy, fluorescent X-ray elemental analysis, or the like.
- composition of the present invention contains (a) a high-intensity sweetener in an amount equivalent to the sweetness intensity X1 (b) a unique phospholipid, and (c) a heterologous phospholipid below the taste recognition threshold.
- the components (a) and (b) exhibit the sweetness of sweetness intensity X2, and the components (a) to (c) exhibit the sweetness of sweetness intensity X3, and 0.1 ⁇ X2 ⁇ X3.
- the high sweetness sweetener is selected from a high sweetness sweetener selected from RebA, RebD, RebM, MogV, Luo Han Guo extract and a combination thereof, preferably from RebD, RebM, MogV, Luo Han Guo extract and a combination thereof.
- High sweetness sweeteners more preferably high sweetness sweeteners selected from RebD, RebM and combinations thereof, X1 is 0.5 to 9.0, preferably 1.0 to 8.0, more preferably 2.0 to 6.0.
- Oral compositions are provided.
- the amount of high-sweetness sweetener is about 20 to about 600 ppm, about 30 to about 550 ppm, about 55 to about 490 ppm, about 20 to about 200 ppm, about 100 to about 500 ppm, or about 150 to about 350 ppm. May be.
- the high sweetness sweetener is optionally selected from RebA, RebD, RebM, MogV, Luo Han Guo extract and a combination thereof, preferably a high sweetness sweetener,
- the high sweetness sweetener is selected from a high sweetness sweetener selected from RebA, RebD, RebM, MogV, Luo Han Guo extract and a combination thereof, preferably from RebD, RebM, MogV, Luo Han Guo extract and a combination thereof.
- Highly sweetened sweeteners more preferably containing high sweetness sweeteners selected from RebD, RebM and combinations thereof. Coffee drinks are provided.
- the high sweetness sweetener is selected from a high sweetness sweetener selected from RebA, RebD, RebM, MogV, Luo Han Guo extract and a combination thereof, preferably from RebD, RebM, MogV, Luo Han Guo extract and a combination thereof.
- Highly sweetened sweeteners more preferably containing high sweetness sweeteners selected from RebD, RebM and combinations thereof. Coffee beverages with milk are provided.
- the present invention provides the following method for producing an oral composition having an increased sweetness (hereinafter, referred to as “the method for producing the present invention”). Includes (a) the addition of a high sweetness sweetener in an amount equivalent to the sweetness intensity X1 and (b) the addition of heterologous phospholipids below the taste recognition threshold to the raw materials of the oral composition containing the inherent phospholipids. , The method for producing an oral composition of the present invention.
- the oral composition produced by the method of the present invention is the oral composition of the present invention described in the above item "1. Oral composition with increased sweetness exhibited by a high-sweetness sweetener".
- the "raw material” in the method of the present invention may be each material or a mixture thereof necessary for producing an oral composition, and further contains additional components such as preservatives, flavors, carriers and fruit juices. May be good. Further, the "raw material” may be composed of a plurality of materials.
- any of the following (a) to (b) may be performed first.
- (A) Add a high-sweetness sweetener in an amount equivalent to the sweetness intensity X1
- (b) Add a heterologous phospholipid below the taste recognition threshold. Further, the two steps may be performed at the same time.
- step (a) an amount of high-sweetness sweetener equivalent to sweetness intensity X1 is added to the raw material, but it is not necessary to add an amount of high-sweetness sweetener equivalent to sweetness intensity X1 at a time. It may be added in divided doses.
- heterologous phospholipids below the taste recognition threshold are added in step (b), it is not necessary to add the heterologous phospholipids below the taste recognition threshold at one time, and the heterologous phospholipids below the taste recognition threshold may be added in several batches.
- the heterologous phospholipid to be added to the raw material in step (b) is selected from those other than the unique phospholipid among the phospholipids described in the above item "1. Oral composition with increased sweetness exhibited by high-sweetness sweeteners". can do.
- addition means an operation of actually adding either the component (a) a high-sweetness sweetener in an amount equivalent to the sweetness intensity X1 and the component (c) a heterologous phospholipid below the taste recognition threshold to the raw material. It also means an operation of adjusting the amounts of the components (a) and (c) in the oral composition finally produced through the production process of the oral composition of the present invention to predetermined amounts.
- the first raw material contains fruit juice, grains and their extracts, so that the raw material contains one or more of the components (a) and (c) in advance and is to be mixed with the first raw material.
- the oral composition of the present invention can be produced by mixing the first and second raw materials, the components (a) and (c) There is no operation to add to the raw materials individually, but in the method of the present invention, the finally produced oral composition of the present invention is (a) a high sweetness sweetener in an amount equivalent to the sweetness intensity X1 and (C) Steps (a) to (b) are considered to have been performed as long as they contain heterologous phospholipids below the taste recognition threshold.
- the production method of one aspect of the present invention further comprises (c) adding a low-sweetness sweetener in an amount equivalent to the sweetness intensity X4.
- the oral composition of Aspect A can be produced.
- the steps (a) to (c) may be performed separately, or two or more steps may be performed at the same time. For example, (a) and (b), (a) and (c), or (a) and (b) and (c) may be performed at the same time.
- oral composition "sweetness intensity X1”, “high sweetness sweetener”, “sweetness intensity X2”, “phospholipid”, “sweetness intensity X3”, “arbitrary component”, “low” “Sweetness sweetener”, “sweetness intensity X4", "other ingredients” and energy are the same as the definitions described in the above oral composition item, and the values are the values described in the above oral composition item. It applies as it is.
- the present invention provides, as a third aspect, a method for enhancing the sweetness of an oral composition (hereinafter, referred to as "the method for enhancing sweetness of the present invention").
- One aspect of the sweetness enhancing method of the present invention is In the manufacture of oral compositions containing unique phospholipids
- An oral composition imparted by a high sweetness sweetener comprising (a) adding a high sweetness sweetener above the taste recognition threshold and (b) adding a heterologous phospholipid below the taste recognition threshold. Concerning how to enhance sweetness.
- the present invention relates to a method for enhancing the sweetness of the oral composition, which comprises adding a heterologous phospholipid below the taste recognition threshold to an oral composition containing a high sweetness sweetener above the taste recognition threshold and a unique phospholipid.
- the sweetness enhancing method of the present invention when the sweetness of an oral composition containing an inherent phospholipid is enhanced and a high sweetness sweetener having a high sweetness degree equal to or higher than the component (a') taste recognition threshold is simply added to the oral composition. It is possible to provide an oral composition having a sweetness exceeding the sweetness intensity. Specifically, a heterologous phospholipid is added to an oral composition containing a unique phospholipid and a high-sweetness sweetener having a taste recognition threshold or higher, and after the addition, a heterogeneous species having a taste recognition threshold of less than the taste recognition threshold is added.
- the oral composition is provided with a sweetness exceeding the sweetness intensity when only a high-sweetness sweetener having a taste recognition threshold value or higher is added.
- the high-intensity sweetener does not have to be contained in the oral composition before the heterologous phospholipid is added, and may be added to the oral composition at the same time as the heterologous phospholipid.
- the type and amount of the heterologous phospholipid to be added are the type and content of the heterologous phospholipid in the oral composition described in the above item "1.
- Oral composition with increased sweetness exhibited by the high-sweetness sweetener Can be selected as.
- the addition of (d') a low-sweetness sweetener having a taste recognition threshold value or higher may be further included.
- the sweetness of the oral composition is enhanced, and the oral composition simply has a high sweetness sweetener having a component (a') taste recognition threshold or higher and a component (d') taste recognition threshold or higher. It is possible to provide an oral composition having a sweetness exceeding the sweetness intensity when a low-sweetness sweetener is added.
- a heterologous phospholipid is added to an oral composition containing a unique phospholipid and a high-sweetness sweetener and a low-sweetness sweetener above the taste recognition threshold, and the heterogeneous phospholipid below the taste recognition threshold.
- the oral composition is provided with a sweetness exceeding the sweetness intensity when only the high sweetness sweetener and the low sweetness sweetener above the taste recognition threshold are added.
- an oral composition containing a unique phospholipid has (b) a heterologous phospholipid below the taste recognition threshold, and (c') a low sweetness degree above the taste recognition threshold.
- a method for enhancing the sweetness of an oral composition which comprises containing a sweetener. According to the enhancing method of this embodiment, it is possible to provide an oral composition that enhances the sweetness of the oral composition and that produces a sweetness that exceeds the sweetness intensity when the component (c') is simply added to the oral composition.
- a heterologous phospholipid is added to an oral composition containing a unique phospholipid and a low-sweetness sweetener having a taste recognition threshold or higher, and after the addition, a heterogeneous species having a taste recognition threshold of less than the taste recognition threshold is added.
- the oral composition is provided with a sweetness exceeding the sweetness intensity when only a low-sweetness sweetener having a taste recognition threshold value or higher is added.
- the type and amount of the heterologous phospholipid to be added are the types of the heterologous phospholipid in the oral composition described in the above item “1. Oral composition with increased sweetness exhibited by the high-sweetness sweetener”. And the content can be selected.
- oral composition In the method for enhancing sweetness of the present invention, "oral composition”, “high sweetness sweetener”, “phospholipid” and “low sweetness sweetener” are the same as the definitions described in the above-mentioned item of oral composition. Yes, the values mentioned in the item of oral composition above are applied as they are.
- the present invention provides, as a fourth aspect, a method for enhancing the texture of the oral composition containing a unique phospholipid (hereinafter referred to as "the method for enhancing the texture of the present invention").
- the method for enhancing the texture of the present invention offers.
- One aspect of the texture enhancing method of the present invention is In the manufacture of oral compositions containing unique phospholipids An oral composition imparted by a high sweetness sweetener, comprising (a) adding a high sweetness sweetener above the taste recognition threshold and (b) adding a heterologous phospholipid below the taste recognition threshold. Regarding how to enhance the texture.
- the present invention relates to a method for enhancing the texture of the oral composition, which comprises adding a heterologous phospholipid below the taste recognition threshold to an oral composition containing a unique phospholipid and a high sweetness sweetener above the taste recognition threshold. ..
- the texture of the oral composition is enhanced, and a texture exceeding the texture when a high sweetness sweetener equal to or higher than the component (a') taste recognition threshold is simply added to the oral composition is produced.
- Oral compositions can be provided. Specifically, a heterologous phospholipid is added to an oral composition containing a unique phospholipid and a high-sweetness sweetener having a taste recognition threshold or higher, and after the addition, the heterogeneous phospholipid having a taste recognition threshold of less than the taste recognition threshold is added to the oral composition.
- the texture of the oral composition can be enhanced more than the texture when only a high-sweetness sweetener having a taste recognition threshold value or higher is added.
- the type and amount of the heterologous phospholipid to be added are the type and content of the heterologous phospholipid in the oral composition described in the above item "1. Oral composition with increased sweetness exhibited by the high-sweetness sweetener". Can be selected as.
- oral composition In the texture enhancing method of the present invention, "oral composition”, "high sweetness sweetener”, “phospholipid”, “texture” and the like are the same as the definitions described in the item of the above oral composition, and their numerical values thereof. The numerical values described in the above-mentioned item of oral composition are applied as they are.
- the present invention provides, as a fifth aspect, a concentrate for providing the following oral composition (hereinafter, referred to as "enhancing method of the present invention”). It contains (a) a high-intensity sweetener in an amount equivalent to the sweetness intensity X1 (b) a unique phospholipid, and (c) a heterologous phospholipid below the taste recognition threshold.
- An oral composition in which the components (a) and (b) exhibit the sweetness of sweetness intensity X2, and the components (a) to (c) exhibit the sweetness of sweetness intensity X3, respectively, and 0.1 ⁇ X2 ⁇ X3.
- the concentrate of the present invention is used to provide an oral composition diluted at any ratio.
- the "oral composition” is the same as that described for "1.
- Oral composition with increased sweetness exhibited by a high-sweetness sweetener" for example, the concentrate of the present invention can be used as a syrup or a stock solution in beverages and the like. At that time, it can be diluted 2-fold, 3-fold, 4-fold, 5-fold, 6-fold, 7-fold, 8-fold, 9-fold or 10-fold before use. Further, since the concentrate of the present invention is concentrated, it is preferable in terms of storage stability and transportability.
- the concentrate of the present invention may be solid or liquid.
- the concentrate of the present invention is a 2 to 10 times concentrate, preferably a 3 to 9 times concentrate, more preferably a 4 to 8 times concentrate, and even more preferably a 4 to 8 times concentrate of the oral composition of the present invention. It is a 5- to 7-fold concentrate.
- the concentrate according to one aspect of the present invention is a 5-fold concentrate of the oral composition of the present invention.
- A High sweetness sweetener in an amount equivalent to sweetness intensity X1a
- the components (a) and (b) exhibit the sweetness of sweetness intensity X2a
- the components (a) to (c) exhibit the sweetness of sweetness intensity X3a, 0.5 ⁇ X2a ⁇ X3a ⁇ 100, preferably 1.0 ⁇ X2a ⁇ X3a ⁇ 50. , More preferably 2.0 ⁇ X2a ⁇ X3a ⁇ 25.
- the concentrate according to another aspect of the present invention is a 10-fold concentrate of the oral composition of the present invention.
- A High sweetness sweetener in an amount equivalent to sweetness intensity X1b
- Inherent phospholipids 10 times the amount in the oral composition and
- the components (a) and (b) exhibit the sweetness of sweetness intensity X2b
- the components (a) to (c) exhibit the sweetness of sweetness intensity X3b, 1.0 ⁇ X2b ⁇ X3b ⁇ 200, preferably 2.0 ⁇ X2b ⁇ X3b ⁇ . 100, more preferably 4.0 ⁇ X2b ⁇ X3b ⁇ 50.
- oral composition A of the present invention provides, as a sixth aspect, the following oral composition (hereinafter, may be referred to as “oral composition A of the present invention”).
- "oral composition", "high sweetness sweetener”, “phospholipid”, “taste recognition threshold”, “low sweetness sweetener”, “texture”, “other components” And energy are the same as the definitions given in the item of the above-mentioned oral composition, and the values mentioned in the item of the above-mentioned oral composition are directly applied.
- the oral composition is substituting for a heterologous phospholipid below the component (c) taste cognitive threshold as a component (c') below the taste cognitive threshold.
- lipids may contain lipids other than the phospholipids of.
- examples of such lipids include lipids containing fatty acids having 8 to 22 carbon atoms, such as triglycerides (particularly triglycerides containing fatty acids having 8 and 10 carbon atoms, such as Actor M-1), and fats and oils derived from hydrogenated coconut oil (eg, emafat). Co-7) and the like.
- the sweetness enhancing effect can also be obtained by these lipids.
- Alternative uses of lipids other than heterologous phospholipids are also applicable to the production methods, sweetness enhancing methods, texture enhancing methods and concentrates of the present invention.
- the word “about” exists in the range of ⁇ 25%, ⁇ 10%, ⁇ 5%, ⁇ 3%, ⁇ 2% or ⁇ 1% of the numerical value following "about” by the subject. Means that. For example, “about 10” means the range of 7.5 to 12.5. As used herein, “mM” means molar concentration, meaning 1 ⁇ 10 -3 mol / L.
- Example 1 Evaluation of the effect of increasing sweetness by adding sodium and phospholipids (1)
- sensory evaluation was performed on beverages using various lipid materials shown in Table 3. 1w / v% sucrose (manufactured by Pacific Sugar Manufacturing Co., Ltd. (same in the following examples), sweetness intensity 1), 3.5w / v% glucose (manufactured by Showa Sangyo Co., Ltd.
- Example 2 Examination of molecular species contained in the lipid material The molecular species of free fatty acids, LPC and PC contained in the lipid material were analyzed.
- (1) Free fatty acid analysis (i) Preparation of standard solution A standard stock solution was prepared by dissolving the fatty acid standard reagent shown in Table 5 in a solvent (methanol, acetone and chloroform). The standard stock solution was mixed and appropriately diluted with methanol to prepare a standard solution having a concentration of each fatty acid of 10 ng / mL to 5000 ng / mL. At this time, an internal standard (fatty acid- 18 O 2 , 67 types, manufactured by Chemicals Evaluation and Research Institute (CERI)) was added to the standard solution so that the concentration was 100 ng / mL in the standard solution.
- a solvent methanol, acetone and chloroform
- the analysis software Lipid Search Ver.4.2 (Mitsui Knowledge Industry) was used for the estimation of lipid molecular species and the alignment between the measured samples. Peak picking, lipid molecular species estimation treatment, and alignment treatment were performed under the conditions shown in Tables 10 and 11. Of the peaks estimated to be derived from LPC and PC, the estimation results were adopted only for the peaks that satisfy all the conditions shown in Table 12. The area value of the detected peak in each sample was corrected by the following formula using the peak area value of phosphatidylcholine 16: 0 D31-18: 1, which is an internal standard.
- Tables 13 to 14 show the molecular species of LPC and PC detected in each sample that meet the conditions of adoption. The peak area values after normalization of each molecular species in each sample are shown in FIGS. 2 to 3.
- an operation blank was also carried out.
- Skim milk products (Yotsuba Milk Products Co., Ltd., the same in the following examples) were added with 0.5 mL of methanol to about 50 mg and about 10 mg, respectively, and ultrasonically extracted, and then shaken with a multi-shaker for 5 minutes. Further, 0.5 mL of chloroform is added and ultrasonically extracted, shaken for 5 minutes with a multi-shaker, and then centrifuged with a micro high-speed cooling centrifuge (MX-207, manufactured by Tomy Seiko), and the supernatant is separated to extract lipids. The liquid was prepared. In addition, an operation blank was also carried out.
- MX-207 micro high-speed cooling centrifuge
- the analysis software MRMPROBS ver.2.60 (RIKEN) was used to detect the peak. Chromatograms were output with a mass error of 10 ppm for the ions of the fatty acid to be analyzed. The area value of the detected peak was divided by the peak area value of the internal standard (fatty acid- 18 O 2 ) to calculate the ratio. A calibration curve was prepared from the peak area ratio of the standard solution and its concentration, and the free fatty acid concentration in the sample was calculated using the calibration curve and the peak area ratio of the sample. The lower limit of quantification was calculated from the lowest concentration with a signal-to-noise ratio (S / N) exceeding 10 at the time of standard solution analysis, using the sample amount and final liquid amount.
- S / N signal-to-noise ratio
- the analysis software Lipid Search Ver.4.2 (Mitsui Knowledge Industry) was used for the estimation of lipid molecular species and the alignment between the measured samples. Peak picking, lipid molecular species estimation treatment, and alignment treatment were performed under the conditions shown in Tables 10 and 11. Of the peaks estimated to be derived from LPC and PC, the estimation results were adopted only for the peaks satisfying all the conditions shown in Table 17. The area value of the detected peak in each sample was corrected by the following formula using the peak area value of phosphatidylcholine 16: 0 D31-18: 1, which is an internal standard.
- Example 4 Measurement of taste recognition threshold of phospholipids The taste recognition thresholds of various phospholipids were examined. For phospholipids derived from soybean, oil palm, rapeseed and sunflower, an aqueous solution having the concentration shown in Table 20 below was prepared. SLP-white as a phospholipid derived from soybean (Material I of Example 2), Emafat PA (N) (Material C of Example 2) as a phospholipid derived from abra palm, and a paste derived from rapeseed as a phospholipid derived from rapeseed.
- the evaluation results are shown in Table 20 below. Based on the above results, compare the total number of people ⁇ and ⁇ with the total number of people ⁇ and ⁇ , and set the concentration at which the latter is more than half of the total number to the upper limit of the taste cognitive threshold, and set the concentration one step lower than the above concentration. It was set to the lower limit of the taste recognition threshold.
- the taste recognition thresholds of phospholipids derived from soybean, abra palm, rapeseed and sunflower were determined to be 12.5 to 25 ⁇ g / mL, 100 to 150 ⁇ g / mL, 25 to 50 ⁇ g / mL and 12.5 to 25 ⁇ g / mL, respectively.
- Example 5 Evaluation of the effect of increasing sweetness by adding phospholipids (1) 1w / v% sucrose, 3.5w / v% glucose and 208ppm RebD dissolved in pure water as a control beverage (Control, sweetness intensity about 8.0), and the control beverage with the phospholipids at the concentrations shown in Table 21.
- the added product was used as a test beverage.
- the sweetness increasing effect was verified by comparing the sweetness intensity of these test beverages with the sweetness intensity of the control beverage by sensory.
- the breakdown and proportion of those who felt that the sweetness of the test beverage was increased as compared with the control beverage are shown in the result column of Table 21.
- Example 6 Evaluation of the effect of increasing sweetness by adding phospholipids
- Control beverage Control beverage (Control) in which 1 w / v% sucrose, 3.5 w / v% glucose and 208 ppm MogV (purity of 95% or more (same in the following examples), sweetness intensity of about 5.6) is dissolved in pure water. , Sweetness intensity about 8.9), a control beverage to which 6.25 ⁇ g / mL soybean-derived phospholipid was added was used as a test beverage. The effect of increasing sweetness was verified by comparing the sweetness intensity of the test beverage with the sweetness intensity of the control beverage by sensory.
- the evaluation was performed by the three-limb forced selection method of "sweeter than the control drink”, “sweeter than the control drink”, and "same sweetness as the control drink” by the panelists who were trained in sensuality (7 people). rice field. Of those who evaluated, 5 (71%) felt that the sweetness of the test beverage was increased compared to the control beverage.
- Example 7 Evaluation of texture increasing effect by addition of phospholipid (1) Using the control beverage and the test beverage prepared in Example 5, the texture of the test beverage was evaluated by the evaluation items of "Mouthfeel", "Thickness / Body” and “Mildness”. did. In each evaluation item, 0 points were given when there was no difference from the control beverage, and points were given in 0.5 point increments from -3 points to 3 points. If the mouthfeel is syrup-like (syrupy), the thickness and body feel, or the mellowness is felt, the score is close to 3 points, and the sweetness rises slower than the control drink. If is watery, does not feel the thickness and body, or does not feel mellow, a score close to -3 was given.
- the evaluation was conducted by panelists who were trained in sensuality (6 to 10 people). The results are shown in FIG. 4 and Table 22.
- the area ratio in Table 22 shows the area ratio of the radar chart when the control beverage is 1.
- Example 8 Evaluation of texture increasing effect by addition of phospholipid (2) Using the control beverage and the test beverage prepared in Example 6, the texture of the test beverage was evaluated in the same manner as in Example 7. The evaluation was conducted by panelists who were trained in sensuality (7 people). The results are shown in Figure 5 and Table 23. The area ratio in Table 23 shows the area ratio of the radar chart when the control beverage is 1.
- Example 9 Effect of addition of phospholipids on the rise of sweetness (1) Using the control beverage and the test beverage prepared in Example 5, the rise in sweetness of the test beverage was evaluated. When there was no difference from the control beverage, 0 points were given, and points were given in 0.5 point increments from -3 points to 3 points. When the sweetness rises faster than the control drink, a score close to 3 points is given, and when the sweetness rises later than the control drink, a score close to -3 points is given. That is, the closer it is to 0, the closer it is to the control beverage. The evaluation was conducted by panelists who were trained in sensuality (6 to 10 people). The results are shown in Table 24.
- Example 10 Effect of addition of phospholipids on the rise of sweetness (2) Using the control beverage and the test beverage prepared in Example 6, the rise in sweetness of the test beverage was evaluated in the same manner as in Example 9. The evaluation was conducted by panelists who were trained in sensuality (7 people). The result was -0.14.
- Example 11 Quantification of the effect of increasing sweetness by adding phospholipids
- a control beverage (Control, sweetness intensity of about 8.0) in which 1 w / v% sucrose, 3.5 w / v% glucose and 208 ppm RebD are dissolved in pure water is used. ), A control beverage to which 6.25 ⁇ g / mL phospholipid (derived from soybean, SLP-white (material I of Example 2), the same in the following Examples unless otherwise specified) was added as a test beverage. ..
- VAS Visual Analogue Scale
- the panelists plot the intensity of sweetness felt at that time on a straight line that defines "I do not feel sweetness” at the left end and "I feel sweetness more than I can think of” at the right end, and sweeten the distance from the left end. It was used as an index of strength. As a result, when the sweetness intensity of the control beverage was 8, the sweetness intensity of the test beverage was 10.2, and the sweetness intensity increased by about 28%.
- Example 12 Evaluation of the effect of increasing sweetness by adding phospholipids (3)
- a control beverage in which 355.2 ppm of RebD was dissolved in pure water was used as a control beverage, and a control beverage in which 6.3 ⁇ g / mL of phospholipid was added was used as a test beverage.
- the sweetness increasing effect was verified by comparing the sweetness intensity of this test beverage with the sweetness intensity of the control beverage by sensory.
- the evaluation was performed by the three-limb forced selection method of "sweeter than the control drink”, “sweeter than the control drink”, and "same sweetness as the control drink” by the panelists who were trained in sensuality (7 people). rice field. Among those who evaluated, 3 out of 7 (43%) felt that the sweetness of the test drink was increased compared to the control drink, and the sweetness of the control drink and the test drink were the same. The number of people was 1 in 7 (14%).
- Example 13 Evaluation of texture increasing effect by addition of phospholipid (3) Using the control beverage and the test beverage prepared in Example 12, the texture of the test beverage was sensory evaluated by the same method as in Example 7. The evaluation was conducted by panelists who were trained in sensuality (7 people). As a result, the mouthfeel, thickness / body feeling, mellowness, and area ratio of the radar chart were 0.07, 0.14, 0.36, and 1.41, respectively (Fig. 6). The area ratio of the radar chart indicates the area ratio of the radar chart when the control beverage is 1.
- Example 14 Effect of addition of phospholipids on the rise of sweetness (3) Using the control beverage and the test beverage prepared in Example 11, the rise in sweetness of the test beverage was sensory-evaluated by the same method as in Example 9. The evaluation was conducted by panelists who were trained in sensuality (7 people). As a result, the rise of sweetness was -0.21.
- Example 15 Effect of addition of phospholipids on taste and texture (1) Ingredients selected from sucrose, glucose, RebD and phospholipids at the ratios shown in Table 25 below were added to 1000 g of coffee extract and mixed to prepare a coffee beverage sample. Each beverage sample was refrigerated until subjected to the following sensory tests.
- the taste and texture of the test beverage (beverage sample containing phospholipids (for example, beverage sample 15-3)) are defined as "Total sweetness”, “Lingering”, and “Thickness / body feeling”. (Thickness / Body) ”,“ Mildness ”,“ Mouthfeel ”and“ Off-taste ”are evaluated.
- 0 points are given when there is no difference from the control beverage (beverage sample having the same composition as the test beverage (for example, beverage sample 15-1) except that it does not contain phospholipids), and 0.5 points from -3 points to 3 points. Scores were given in dot increments.
- Example 16 Effect of addition of phospholipids on taste and texture
- a component selected from phospholipids were added to 1000 g of coffee extract and mixed to prepare a coffee beverage sample. Each beverage sample was refrigerated until subjected to the following sensory tests.
- test beverage (beverage sample containing phospholipids (eg, beverage sample 16-2)) was adjusted to that of the control beverage (beverage sample 16-1 having the same composition as the test beverage except that it did not contain phospholipids).
- control beverage beverage sample 16-1 having the same composition as the test beverage except that it did not contain phospholipids.
- evaluation was performed in the same manner as in Example 15. The results are shown in Table 28.
- Example 17 Effect of addition of phospholipids on taste and texture (3) Ingredients selected from sucrose, glucose, RebD and phospholipids at the ratios shown in Table 29 below were added to 1000 g of coffee extract and mixed to prepare a coffee beverage sample. Each beverage sample was refrigerated until subjected to the following sensory tests.
- Example 18 Effect of addition of phospholipids on taste and texture (4)
- Ingredients selected from skim milk powder, sucrose, glucose, RebD and phospholipids were added to 1000 g of coffee extract and mixed at the ratios shown in Table 31 below to prepare a coffee beverage sample containing milk. Each beverage sample was refrigerated until subjected to the following sensory tests.
- test beverages (beverage samples 18-2 to 18-3) compared with the control beverage (beverage sample 18-1) were evaluated in the same manner as in Example 15. The results are shown in Table 32.
- Example 19 Effect of addition of phospholipids on taste and texture (5) Selected from sucrose, glucose, RebD and phospholipids (rapeseed paste lecithin (material A of Example 2) or sunflower powder lecithin (material B of Example 2)) in the proportions shown in Table 33 below. The ingredients were added to 1000 g of coffee extract and mixed to prepare a coffee beverage sample. Each beverage sample was refrigerated until subjected to the following sensory tests.
- Example 20 Effect of addition of phospholipids on taste and texture (6) From defatted milk powder, sucrose, glucose, RebD and phospholipids (rapeseed-derived paste-like lecithin (material A of Example 2) or sunflower-derived powdered lecithin (material B of Example 2)) in the ratio shown in Table 35 below.
- the selected ingredients were added to 1000 g of coffee extract and mixed to prepare a coffee beverage sample containing milk. Each beverage sample was refrigerated until subjected to the following sensory tests.
- test beverages (beverage samples 20-2 to 20-3) compared with the control beverage (beverage sample 20-1) were evaluated in the same manner as in Example 15. The results are shown in Table 36.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tea And Coffee (AREA)
- Cosmetics (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
Description
[1] (a)甘味強度X1相当の量の高甘味度甘味料、
(b)固有のリン脂質、及び
(c)味覚認知閾値未満の異種リン脂質
を含み、
前記成分(a)及び(b)により甘味強度X2の甘味を、前記成分(a)~(c)により甘味強度X3の甘味をそれぞれ呈し、0.1<X2<X3である、経口組成物。
[2] 前記リン脂質が、炭素数16以上の脂肪酸を有する、[1]に記載の経口組成物。
[3] 低甘味度甘味料をさらに含む、[1]又は[2]に記載の経口組成物。
[4] 前記高甘味度甘味料が、ステビア抽出物、羅漢果抽出物、ステビオール配糖体、モグロシド及びその組合せから選択される高甘味度甘味料を含む、[1]~[3]のいずれか一項に記載の経口組成物。
[5] 前記低甘味度甘味料が、ブドウ糖、ショ糖、果糖、麦芽糖、異性化糖、乳糖、プシコース、アロース、タガトース、キシロース、リボース及びその組合せから選択される低甘味度甘味料を含む、[3]又は[4]に記載の経口組成物。
[6] 飲料である、[1]~[5]のいずれか一項に記載の経口組成物。
[7] 飲料が、コーヒー飲料、乳飲料、乳性飲料及び豆乳飲料から選択される、[6]に記載の経口組成物。
[8] 固有のリン脂質がコーヒー豆に由来するリン脂質であり、異種リン脂質がダイズ、ナタネ、ヒマワリ、アブラヤシ、ゴマ、トウモロコシ、ラッカセイ、オリーブ、ワタ、アマ、卵黄及び乳から選択される材料に由来するリン脂質である、[1]~[7]のいずれか一項に記載の経口組成物。
[9] 固有のリン脂質を含む経口組成物の原材料に
(a)甘味強度X1相当の量の高甘味度甘味料を添加すること、及び
(b)味覚認知閾値未満のリン脂質を添加すること
を含む、[1]~[8]のいずれか一項に記載の経口組成物の製造方法。
[10] 固有のリン脂質を含む経口組成物の製造において、
(a)味覚認知閾値以上の高甘味度甘味料を添加すること、及び
(b)味覚認知閾値未満のリン脂質を添加すること
を含む、高甘味度甘味料により付与される経口組成物の甘味を増強する方法。
[11] (a)約20~約600ppmの高甘味度甘味料、
(b)固有のリン脂質、及び
(c)約250μg/mL未満のリン脂質
を含む、経口組成物。
なお、本明細書において引用した全ての文献、及び公開公報、特許公報その他の特許文献は、参照として本明細書に組み込むものとする。また、本明細書は、本願優先権主張の基礎となる2020年12月28日に出願された日本国特許出願(特願2020-218717号)及び2021年9月3日に出願された日本国特許出願(特願2021-144319号)の明細書及び図面に記載の内容を包含する。
本明細書において、例えば、飲料に係る「A成分の含有量がXmg/100mLである」との記載は、「飲料100mLに対して、A成分がXmg含まれている」ことを意味する。飲料の比重は凡そ1であるため、飲料において、「mg/100g」は「mg/100mL」と同視し得る。固形の組成物など、単位の分母を容積で表すことが適切でない場合は分母を質量に読み替えるものとする(例えば、「mg/100mL」は「mg/100g」と読み替えるものとする)。又、例えば、飲料に係る「B成分の含有量がYppmである」との記載は、「飲料の全量(100質量%)に対して、B成分がYppm含まれている」ことを意味する。
本発明は、第1の態様として、以下の経口組成物(以下、「本発明の経口組成物」という)を提供する。
(a)甘味強度X1相当の量の高甘味度甘味料、
(b)固有のリン脂質、及び
(c)味覚認知閾値未満の異種リン脂質
を含み、
前記成分(a)及び(b)により甘味強度X2の甘味、前記成分(a)~(c)により甘味強度X3の甘味をそれぞれ呈し、0.1<X2<X3である、経口組成物。
本明細書において、「経口組成物」は固体、半固体、半流動体、及び液体、ならびにそれらの混合物であって、経口摂食可能なものの総称である。本発明の経口組成物には、食品が包含され、食品には飲料が包含される。本発明の経口組成物の例としては、一般食品、栄養補助食品、健康食品、機能性食品、幼児用食品、老人用食品等が挙げられる。
コーヒー飲料の形態は限定されず、例えば濃縮コーヒーエキスやインスタントコーヒーを溶解させた飲料の形態としてもよく、缶、PETボトル等の容器に封入して容器詰めされた容器詰コーヒー飲料の形態としてもよい。
菓子類の例としては、飴、ジャム、チューインガム、アイスクリーム、スナック菓子、クッキー、ビスケット、ケーキ、ウェハース、菓子パン、チョコレート、和菓子等が挙げられるがこれらに限定されるものではない。
さらに、本発明の経口組成物は容器詰め殺菌されたものであってもよい。
本明細書において、「甘味強度」は物質の呈する甘味の強さを意味する。例えば、単位濃度Brix1当たりのショ糖が呈する甘味強度を甘味度1と定めた場合、ブドウ糖の甘味度は0.6~0.7(中心値0.65)となる。この甘味度にブドウ糖の濃度Brix値を乗じて得られる数値がブドウ糖の甘味強度となる。したがって、ブドウ糖の濃度がBrix1.5の場合、ブドウ糖の甘味強度は0.65×1.5=0.975となる。
さらには、上記測定において本発明の経口組成物よりも甘味が少ない基準経口組成物のうち、本発明の経口組成物と最も甘味の近い基準経口組成物を選択し、当該選択された基準経口組成物にショ糖を追加することによって本発明の経口組成物と同じ甘味を呈するように調整し、その際に、調整後の基準経口組成物に含まれるショ糖含有量から、本発明の経口組成物について甘味強度を測定することもできる。
一態様において、本発明の経口組成物は、成分(c)によりテクスチャーが増大している。経口組成物のテクスチャーは、口当たり、厚み、ボディ感、まろやかさ、舌触り、口触り、喉ごし、歯ごたえ、歯切れ、食感といった、経口組成物のおいしさの物理的性質に関する因子である。テクスチャーは、官能試験や食感測定器(テンシプレッサー)などにより評価することができる。飲料などの液状の経口組成物については、官能試験による評価が好ましい。成分(c)によりテクスチャーが増大したか否かは、例えば、官能に関して訓練を受けたパネラーにより、本発明の経口組成物と、成分(c)を含まない以外は本発明の経口組成物と同じ組成の経口組成物(以下、「対照組成物」と称することがある)とを、テクスチャーに関する項目について比較することで評価することができる。
高甘味度甘味料(本明細書中、「甘味料(a)」又は「成分(a)」と略すことがある)は、ショ糖に比べて強い甘味を有する化合物を意味し、天然由来化合物、合成化合物又は天然由来化合物及び合成化合物の組合せを包含する。高甘味度甘味料はショ糖と同量において、ショ糖より5倍以上、10倍以上、50倍以上、100倍以上、500倍以上、1,000倍以上、5,000倍以上、10,000倍以上、50,000倍以上又は100,000倍以上の甘味を呈する。
カンゾウ(甘草)抽出物とは、ウラルカンゾウ、チョウカカンゾウ又はヨウカンゾウの根又は根茎から得られた、グリチルリチン酸を主成分とするものをいう。カンゾウ抽出物の例としてはカンゾウエキス、グリチルリチン、リコリス抽出物が挙げられる。
ショ糖誘導体は、例えば、ショ糖のOH基又はH基を別の置換基で置換して得られるものを含み、その例としては、ショ糖のハロゲン誘導体(スクラロース)、オキサチアジノンジオキシド誘導体等が挙げられる。
本発明に用いられるリン脂質は、リン原子をリン酸エステルの形で構造中に有する両親媒性の脂質である。リン脂質は、グリセリンを骨格とするグリセロリン脂質と、スフィンゴシンを骨格とするスフィンゴリン脂質とを包含する。グリセロリン脂質は、典型的にはグリセリンの1、2位に脂肪酸、3位にリン酸がそれぞれエステル結合し、リン酸基に、コリン、エタノラミン、セリン、イノシトールなどのアルコールがエステル結合した構造を有する。グリセリン、リン酸基及びアルコールエステルを含む極性(親水性)部分を頭部、非極性(疎水性)の脂肪酸を尾部と称する。又、グリセリン、脂肪酸及びリン酸を含む部分構造をホスファチジン酸と称する。グリセロリン脂質の非限定例としては、例えば、ホスファチジルコリン(PC)、ホスファチジルエタノールアミン(PE)、ホスファチジルイノシトール(PI)、ホスファチジルセリン(PS)、ホスファチジルグリセロール(PG)、カルジオリピンなどが挙げられる。スフィンゴリン脂質の非限定例としては、例えば、スフィンゴミエリン(SM)等が挙げられる。通常のリン脂質は、グリセリンやスフィンゴシン等の基本骨格に脂肪酸が2個結合しているが、脂肪酸が1個のみ結合したリン脂質をリゾリン脂質と呼ぶ。リゾリン脂質の非限定例としては、リゾホスファチジルコリン(LPC)、リゾホスファチジルエタノールアミン(LPE)、リゾホスファチジルイノシトール(LPI)、リゾホスファチジルセリン(LPS)、リゾホスファチジルグリセロール(LPG)などのリゾグリセロリン脂質、リゾスフィンゴミエリン(LSM)などのリゾスフィンゴリン脂質が挙げられる。リゾグリセロリン脂質は、グリセリンの1位又は2位に脂肪酸が結合している。一態様において、リン脂質はリゾリン脂質を含む。一態様において、リン脂質は双性イオン性リン脂質を含む。双性イオン性リン脂質は、分子内に正電荷と負電荷の両方を有する脂質である。双性イオン性リン脂質の非限定例としては、PC、PE、LPC、LPE等が挙げられる。特定の態様において、リン脂質は双性イオン性リゾリン脂質(例えばLPC、LPE)を含む。
本発明の経口組成物は、固有のリン脂質を含む。固有のリン脂質は、経口組成物固有の成分として含まれているリン脂質を指す。固有のリン脂質は、経口組成物を構成する原料に由来しても、経口組成物の種類に応じて通常使用される添加剤に由来してもよい。前者の非限定例としては、例えば、コーヒー飲料におけるコーヒー豆に由来するリン脂質、豆乳飲料におけるダイズに由来するリン脂質、乳飲料における乳に由来するリン脂質等が挙げられ、後者の非限定例としては、例えば、アイスクリーム、マーガリン、菓子類、調整粉乳などに乳化剤として含まれているリン脂質等が挙げられる。
本発明の経口組成物は(c)味覚認知閾値未満の異種リン脂質を含む。異種リン脂質は、固有のリン脂質とは異なる種類のリン脂質を指す。異種リン脂質は、固有のリン脂質以外のリン脂質であるということもできる。固有のリン脂質とは異なる種類とは、例えば、固有のリン脂質が1種類のみであれば、異種リン脂質は、固有のリン脂質以外の任意のリン脂質(1種又は複数種の組合せ)であり得る。固有のリン脂質が複数のリン脂質の混合物である場合、異種リン脂質は固有のリン脂質に含まれないリン脂質又はそのリン脂質を含むリン脂質の組合せであってよい。例えば、固有のリン脂質がリン脂質A及びBの組合せからなる場合、異種リン脂質はリン脂質A及びBとは異なるリン脂質Cであるか、リン脂質Cと他の任意のリン脂質との組合せであってもよい(リン脂質Cを含む限りにおいて、リン脂質A及び/又はBを含むリン脂質の組合せであってもよい)。また、固有のリン脂質とは異なる種類とは、例えば、固有のリン脂質が由来する素材(例えば、生物、食材など)とは異なる素材に由来するリン脂質であってもよい。具体的には、例えば、コーヒー飲料がコーヒー豆に由来するリン脂質のみを含む場合は、異種リン脂質はコーヒー豆に由来するリン脂質以外のリン脂質(例えばダイズ、ナタネ、ヒマワリ、アブラヤシ、ゴマ、トウモロコシ、ラッカセイ、オリーブ、ワタ、アマ、卵黄、乳等に由来するリン脂質)であり、豆乳飲料がダイズに由来するリン脂質のみを含む場合は、異種リン脂質はダイズに由来するリン脂質以外のリン脂質(例えばナタネ、ヒマワリ、アブラヤシ、ゴマ、トウモロコシ、ラッカセイ、オリーブ、ワタ、アマ、コーヒー、卵黄、乳等に由来するリン脂質)であり、乳飲料が乳に由来するリン脂質のみを含む場合は、異種リン脂質は乳に由来するリン脂質以外のリン脂質(例えばダイズ、ナタネ、ヒマワリ、アブラヤシ、ゴマ、トウモロコシ、ラッカセイ、オリーブ、ワタ、アマ、コーヒー、卵黄等に由来するリン脂質)である。
(甘味料)
本発明の経口組成物は、成分(a)の高甘味度甘味料以外にも甘味料を含み得る。本明細書において「甘味料」は甘味応答を引き起こす任意の物質又は物質群を意味する。甘味料は、構造上の特徴から糖質系甘味料と非糖質系甘味料に、又、甘味度に基づき、低甘味度甘味料と高甘味度甘味料に分けることができる。又、エネルギー(カロリー)に基づき、甘味物質をカロリー性甘味料と非カロリー性甘味料に分けることもできる。さらに入手方法に基づき、天然甘味料と人工甘味料に分けることもできる。
(a)甘味強度X1相当の量の高甘味度甘味料
(b)固有のリン脂質
(c)味覚認知閾値未満の異種リン脂質、及び
(d)甘味強度X4相当の量の低甘味度甘味料(本明細書中、「成分(d)」と略すことがある。)
を含み、
前記成分(a)及び(b)により甘味強度X2の甘味、前記成分(a)~(d)により甘味強度X5の甘味を呈し、0.1<X2+X4<X5である、経口組成物。本発明の一態様における経口組成物は、(a)甘味強度X1相当の量の高甘味度甘味料と(d)甘味強度X4相当の量の低甘味度甘味料以外の成分を甘味料として含まない。
低甘味度甘味料の甘味強度X4相当の量とは、本発明の経口組成物と同等体積の20℃の水に低甘味度甘味料を溶かした条件で甘味強度X4の甘味を呈する量(濃度)をいう。
本発明の経口組成物は、本発明の効果を損なわない限りにおいて、酸化防止剤(エリソルビン酸ナトリウムなど)、乳化剤(ショ糖脂肪酸エステル、ソルビタン脂肪酸エステル、ポリグリセリン脂肪酸エステルなど)、酸味料(リン酸、クエン酸、リンゴ酸など)、香料等を適宜配合することができる。
一態様において、本発明の経口組成物はナトリウムを実質的に含まない。実質的に含まないとは、例えば、経口組成物にナトリウムが検出されない(すなわち、検出限界未満である)ことを意味する。ナトリウムの検出は、例えば原子吸光法、蛍光X線元素分析などにより検出することができる。
本発明の一態様において、
(a)甘味強度X1相当の量の高甘味度甘味料
(b)固有のリン脂質、及び
(c)味覚認知閾値未満の異種リン脂質
を含み、
前記成分(a)及び(b)により甘味強度X2の甘味、前記成分(a)~(c)により甘味強度X3の甘味をそれぞれ呈し、0.1<X2<X3であり、
前記高甘味度甘味料が、RebA、RebD、RebM、MogV、羅漢果抽出物及びその組合せから選択される高甘味度甘味料、好ましくはRebD、RebM、MogV、羅漢果抽出物及びその組合せから選択される高甘味度甘味料、より好ましくは、RebD、RebM及びその組合せから選択される高甘味度甘味料、を含み、
X1が、0.5~9.0、好ましくは1.0~8.0、より好ましくは2.0~6.0である、
経口組成物が提供される。
本態様において、高甘味度甘味料の量は、約20~約600ppm、約30~約550ppm、約55~約490ppm、約20~約200ppm、約100~約500ppm又は約150~約350ppmであってもよい。
(a)約20~約600ppmの高甘味度甘味料
(b)固有のリン脂質、及び
(c)約250μg/mL未満、約10~約250μg/mL、約1.6125~約12.5μg/mL、約3.125~約12.5μg/mL、約3.125~約25μg/mL、約6.25~約25μg/mL、約6.25~約50μg/mL、約12.5~約25μg/mL、約25~約50μg/mL、約100~約150μg/mL又は約100~約200μg/mLの異種リン脂質
を含み、
前記高甘味度甘味料が、任意選択で、RebA、RebD、RebM、MogV、羅漢果抽出物及びその組合せから選択される高甘味度甘味料、好ましくはRebD、RebM、MogV、羅漢果抽出物及びその組合せから選択される高甘味度甘味料、より好ましくは、RebD、RebM及びその組合せから選択される高甘味度甘味料を含む、
経口組成物が提供される。
(a)約20~約600ppmの高甘味度甘味料
(b)コーヒー由来の固有のリン脂質、及び
(c)約10~約250μg/mL、約1.6125~約12.5μg/mL、約3.125~約12.5μg/mL、約3.125~約25μg/mL、約6.25~約25μg/mL、約6.25~約50μg/mL、約12.5~約25μg/mL、約25~約50μg/mL、約100~約150μg/mL又は約100~約200μg/mLの異種リン脂質、例えば、約25μg/mL未満、約3.125~約25μg/mL又は約6.25~約25μg/mLのダイズ由来のリン脂質
を含み、
前記高甘味度甘味料が、RebA、RebD、RebM、MogV、羅漢果抽出物及びその組合せから選択される高甘味度甘味料、好ましくはRebD、RebM、MogV、羅漢果抽出物及びその組合せから選択される高甘味度甘味料、より好ましくは、RebD、RebM及びその組合せから選択される高甘味度甘味料を含む、
コーヒー飲料が提供される。
(a)約20~約600ppmの高甘味度甘味料
(b)コーヒー及び乳由来の固有のリン脂質、及び
(c)約10~約250μg/mL、約1.6125~約12.5μg/mL、約3.125~約12.5μg/mL、約3.125~約25μg/mL、約6.25~約25μg/mL、約6.25~約50μg/mL、約12.5~約25μg/mL、約25~約50μg/mL、約100~約150μg/mL又は約100~約200μg/mLの異種リン脂質、例えば、約25μg/mL未満、約3.125~約25μg/mL又は約6.25~約25μg/mLのダイズ由来のリン脂質
を含み、
前記高甘味度甘味料が、RebA、RebD、RebM、MogV、羅漢果抽出物及びその組合せから選択される高甘味度甘味料、好ましくはRebD、RebM、MogV、羅漢果抽出物及びその組合せから選択される高甘味度甘味料、より好ましくは、RebD、RebM及びその組合せから選択される高甘味度甘味料を含む、
ミルク入りコーヒー飲料が提供される。
本発明は、第2の態様として、以下の甘味が増大された経口組成物の製造方法(以下、「本発明の製造方法」という)を提供する。
固有のリン脂質を含む経口組成物の原材料に
(a)甘味強度X1相当の量の高甘味度甘味料を添加すること、及び
(b)味覚認知閾値未満の異種リン脂質を添加すること
を含む、本発明の経口組成物の製造方法。
(a)甘味強度X1相当の量の高甘味度甘味料を添加すること
(b)味覚認知閾値未満の異種リン脂質を添加すること
又、2つの工程が同時に行われてもよい。
例えば、第1の原材料に果汁、穀類やその抽出物が含まれ、そのために原材料に予め成分(a)及び(c)のいずれか1つ以上が含まれ、第1の原材料と混合するための第2の原材料においても成分(a)及び(c)が含まれ、第1及び第2の原材料を混合することにより本発明の経口組成物が製造できた場合、成分(a)及び(c)を個別に原材料に追加する操作は存在していないが、本発明の方法では、最終的に製造される本発明の経口組成物が(a)甘味強度X1相当の量の高甘味度甘味料及び(c)味覚認知閾値未満の異種リン脂質を含む限り、工程(a)~(b)は行われたものとみなす。
本発明は、第3の態様として、経口組成物の甘味を増強する方法(以下、「本発明の甘味増強方法」という)を提供する。
本発明の甘味増強方法の一態様は、
固有のリン脂質を含む経口組成物の製造において、
(a)味覚認知閾値以上の高甘味度甘味料を添加すること、及び
(b)味覚認知閾値未満の異種リン脂質を添加すること
を含む、高甘味度甘味料により付与される経口組成物の甘味を増強する方法
に関する。
本発明の甘味増強方法の別の態様は、
味覚認知閾値以上の高甘味度甘味料と固有のリン脂質とを含む経口組成物に、味覚認知閾値未満の異種リン脂質を添加することを含む、前記経口組成物の甘味を増強する方法
に関する。
本態様の甘味増強方法によれば、経口組成物の甘味を増強し、単に経口組成物に成分(a')味覚認知閾値以上の高甘味度甘味料及び成分(d')味覚認知閾値以上の低甘味度甘味料を添加したときの甘味強度を超える甘味を奏する経口組成物を提供することができる。具体的には、固有のリン脂質と、味覚認知閾値以上の高甘味度甘味料及び低甘味度甘味料とを含む経口組成物に、異種リン脂質を添加して味覚認知閾値未満の異種リン脂質が含まれるようにすることで、味覚認知閾値以上の高甘味度甘味料及び低甘味度甘味料のみを添加した場合の甘味強度を超える甘味を当該経口組成物にもたらす。
(b)味覚認知閾値未満の異種リン脂質、及び
(c')味覚認知閾値以上の低甘味度甘味料
を含有させることを特徴とする、経口組成物の甘味を増強する方法が提供される。
本態様の増強方法によれば、経口組成物の甘味を増強し、単に経口組成物に成分(c')を添加したときの甘味強度を超える甘味を奏する経口組成物を提供することができる。具体的には、固有のリン脂質と、味覚認知閾値以上の低甘味度甘味料とを含む経口組成物に異種リン脂質を添加して、添加後に当該経口組成物中に味覚認知閾値未満の異種リン脂質が含まれるようにすることで、味覚認知閾値以上の低甘味度甘味料のみを添加した場合の甘味強度を超える甘味を当該経口組成物にもたらす。この態様においても、添加する異種リン脂質の種類及び量は、上記項目「1.高甘味度甘味料の呈する甘味が増大された経口組成物」で述べた経口組成物中の異種リン脂質の種類及び含有量となるように選択することができる。
本発明は、第4の態様として、固有のリン脂質を含む経口組成物のテクスチャーを増強する方法(以下、「本発明のテクスチャー増強方法」という)を提供する。
本発明のテクスチャー増強方法の一態様は、
固有のリン脂質を含む経口組成物の製造において、
(a)味覚認知閾値以上の高甘味度甘味料を添加すること、及び
(b)味覚認知閾値未満の異種リン脂質を添加すること
を含む、高甘味度甘味料により付与される経口組成物のテクスチャーを増強する方法
に関する。
本発明のテクスチャー増強方法の別の態様は、
固有のリン脂質と、味覚認知閾値以上の高甘味度甘味料とを含む経口組成物に、味覚認知閾値未満の異種リン脂質を添加することを含む、前記経口組成物のテクスチャーを増強する方法
に関する。
本発明は、第5の態様として、以下の経口組成物を提供するための濃縮物(以下、「本発明の増強方法」という)を提供する。
(a)甘味強度X1相当の量の高甘味度甘味料
(b)固有のリン脂質、及び
(c)味覚認知閾値未満の異種リン脂質
を含み、
前記成分(a)及び(b)により甘味強度X2の甘味、前記成分(a)~(c)により甘味強度X3の甘味をそれぞれ呈し、0.1<X2<X3である経口組成物。
本発明の濃縮物は、本発明の経口組成物の2~10倍濃縮物であり、好ましくは3~9倍濃縮物であり、より好ましくは、4~8倍濃縮物であり、さらに好ましくは5~7倍濃縮物である。
(a)甘味強度X1a相当の量の高甘味度甘味料
(b)経口組成物における量の5倍の固有のリン脂質、及び
(c)味覚認知閾値の5倍未満の異種リン脂質
を含み、
前記成分(a)及び(b)により甘味強度X2aの甘味、前記成分(a)~(c)により甘味強度X3aの甘味を呈し、0.5<X2a<X3a<100、好ましく1.0<X2a<X3a<50、より好ましくは2.0<X2a<X3a<25である。
(a)甘味強度X1b相当の量の高甘味度甘味料
(b)経口組成物における量の10倍の固有のリン脂質、及び
(c)味覚認知閾値の10倍未満の異種リン脂質
を含み、
前記成分(a)及び(b)により甘味強度X2bの甘味、前記成分(a)~(c)により甘味強度X3bの甘味をそれぞれ呈し、1.0<X2b<X3b<200、好ましく2.0<X2b<X3b<100、より好ましくは4.0<X2b<X3b<50である。
本発明は、第6の態様として、以下の経口組成物(以下、「本発明の経口組成物A」ということがある)を提供する。
(a')味覚認知閾値以上の高甘味度甘味料
(b)固有のリン脂質、及び
(c)味覚認知閾値未満の異種リン脂質
を含み、
前記成分(c)によりテクスチャーが増大している、経口組成物。
本発明の経口組成物Aにおいて、「経口組成物」、「高甘味度甘味料」、「リン脂質」、「味覚認知閾値」、「低甘味度甘味料」、「テクスチャー」、「その他の成分」及びエネルギーは、上記経口組成物の項目で述べた定義と同様であり、その数値は上記経口組成物の項目で述べた数値がそのまま当てはまる。
本発明の別の態様において、経口組成物は、成分(c)味覚認知閾値未満の異種リン脂質に代えて、成分(c')として味覚認知閾値未満のリン脂質以外の脂質を含んでもよい。かかる脂質としては、例えば、炭素数8~22の脂肪酸を含む脂質、例えばトリグリセリド(特に炭素数8及び10の脂肪酸を含むトリグリセリド、例えばアクターM-1)、ヤシ硬化油由来の油脂(例えばエマファットCo-7)等が挙げられる。これらの脂質によっても甘味増強効果を得ることができる。異種リン脂質以外の脂質の代替的な利用は、本発明の製造方法、甘味増強方法、テクスチャー増強方法及び濃縮物にも適用可能である。
脂質とナトリウムとを甘味飲料に加えた際の甘味増大効果を評価するために、表3に示す種々の脂質素材を用いた飲料について官能評価を行った。
1w/v%のショ糖(太平洋製糖株式会社製(以下の実施例において同じ)、甘味強度1)、3.5w/v%のブドウ糖(昭和産業株式会社製(以下の実施例において同じ)、甘味強度約2.3)、208ppmのレバウジオシドD(RebD)(純度95%以上(以下の実施例において同じ)、甘味強度約4.7)及び5mMのグルコン酸ナトリウム(純度98%以上(以下の実施例において同じ)、Na量として11.5mg/100mL)を純水に溶解したものを対照飲料(Control)とし、これに表3に示す味覚認知閾値未満の濃度の種々の脂質素材を加えたものを試験飲料とした。各脂質素材の味覚認知閾値は、事前に官能試験により決定した。これら試験飲料の甘味強度を対照飲料の甘味強度と官能により比較することで、脂質による甘味増大効果を検証した。評価は、官能に関して訓練を受けた者(4~8名)がパネラーとなり、「試験飲料の方が甘い」、「対照飲料の方が甘い」、「甘さが同じ」の三肢強制選択法により行った。評価を行った者のうち、対照飲料と比較して甘味が増大していると感じた者の内訳及び割合を表4の結果欄に示した。例えば、7人が評価して4人が甘味の増大を感じた試験飲料については、内訳欄に「4/7」、%欄に57と記載した。なお、ナトリウムが甘味飲料の甘味を増大することはWO2018/225817より知られていることから、本実験における甘味が増大しているとの評価は、ナトリウムによりすでに増大している甘味料の甘味が、脂質によりさらに増大したことを意味する。
脂質素材に含まれる遊離脂肪酸、LPC及びPCの分子種を分析した。
(1)遊離脂肪酸解析
(i)標準溶液の調製
表5に示す脂肪酸標準試薬を溶媒(メタノール、アセトン及びクロロホルム)に溶解して標準原液を調製した。標準原液を混合し、適宜メタノールで希釈して、各脂肪酸の濃度が10ng/mL~5000ng/mLの標準溶液を調製した。この時、標準溶液には内部標準(脂肪酸-18O2、67種、化学物質評価研究機構(CERI)製)を、濃度が標準溶液中で100ng/mLとなるように添加した。
表6に示す実施例2で使用した各種脂質素材約50mgに1mLのメタノール/クロロホルム(1/1 v/v)を加えて超音波抽出後、マルチシェーカーで5分間振とうし、微量高速冷却遠心機(MX-207、トミー精工製)で遠心分離を行い、脂質抽出液を調製した。又、操作ブランクも実施した。
上記(ii)で得た脂質抽出液をメタノールで適宜希釈し、分析試料を調製した。この時、内部標準(脂肪酸-18O2)濃度が分析試料中で100ng/mLとなるように添加した。得られた分析試料の遊離脂肪酸組成を表7に示す分析条件で解析した。
(i)分析試料の調製及び解析
上記(1)(ii)で得た脂質抽出液2μLに、メタノール中のホスファチジルコリン16:0 D31-18:1(Avanti Polar Lipids)を500ng/mL添加することで分析試料を調製した。又、調製した分析試料をそれぞれ10μLずつ分取、混合してQC試料を調製した。得られた分析試料のLPC及びPC組成を表9に示す分析条件で解析した。
[NMArea]:補正後の各試料中の各ピーク面積値
[MainArea]:各試料中の各ピーク面積値
[MainArea IS]:各試料中のホスファチジルコリン16:0 D31-18:1のピーク面積値
[MainArea IS,Min]:全試料中で最小のホスファチジルコリン16:0 D31-18:1のピーク面積値
食品に含まれる固有の遊離脂肪酸、LPC及びPCの分子種を分析した。
(1)遊離脂肪酸解析
(i)標準溶液の調製
上記表5に示す脂肪酸標準試薬を溶媒(メタノール、アセトン及びクロロホルム)に溶解して標準原液を調製した。標準原液を混合し、適宜メタノールで希釈して、各脂肪酸の濃度が10ng/mL~2500ng/mLの標準溶液を調製した。この時、標準溶液には内部標準(脂肪酸-18O2、67種、化学物質評価研究機構(CERI)製)を、濃度が標準溶液中で200ng/mLとなるように添加した。
コーヒー抽出液(コーヒーエキスとpH調整剤の混合液、カフェイン含有量:40mg/100mL、ナトリウム含有量:17.7mg/100g、以下の実施例において同じ)400μL及び200μLを各々凍結乾燥した後、0.5mLのメタノールを加えて超音波抽出後、マルチシェーカーで5分間振とうした。更にクロロホルム0.5mLを加えて超音波抽出し、マルチシェーカーで5分間振とうした後、微量高速冷却遠心機(MX-207、トミー精工製)で遠心分離を行い、上澄みを分取して脂質抽出液を調製した。また、操作ブランクも実施した。
脱脂粉乳(よつ葉乳業株式会社、以下の実施例において同じ)約50mg及び約10mgに各々0.5mLのメタノールを加えて超音波抽出後、マルチシェーカーで5分間振とうした。更にクロロホルム0.5mLを加えて超音波抽出し、マルチシェーカーで5分間振とうした後、微量高速冷却遠心機(MX-207、トミー精工製)で遠心分離を行い、上澄みを分取して脂質抽出液を調製した。また、操作ブランクも実施した。
上記(ii)で得た脂質抽出液を乾固した後、メタノールに再溶解し、分析試料を調製した。この時、内部標準(脂肪酸-18O2)濃度が分析試料中で200ng/mLとなるように添加した。得られた分析試料の遊離脂肪酸組成を表7に示す分析条件で解析した。
(i)分析試料の調製及び解析
上記(1)(ii)で得た脂質抽出液を乾固した後、ホスファチジルコリン16:0 D31-18:1(Avanti Polar Lipids)を既知量添加し、分析試料を調製した。得られた分析試料のLPC及びPC組成を表9に示す分析条件で解析した。
[NMArea]:補正後の各試料中の各ピーク面積値
[MainArea]:各試料中の各ピーク面積値
[MainArea IS]:各試料中のホスファチジルコリン16:0 D31-18:1のピーク面積値
[MainArea IS,Min]:全試料中で最小のホスファチジルコリン16:0 D31-18:1のピーク面積値
[Concentration ratio]:試料の濃縮倍率
[Sample weight]:試料質量(mg)
各種リン脂質の味覚認知閾値を検討した。ダイズ、アブラヤシ、ナタネ及びヒマワリ由来のリン脂質について、下記表20の濃度の水溶液を調製した。ダイズ由来のリン脂質としてSLP-ホワイト(実施例2の素材I)、アブラヤシ由来のリン脂質としてエマファットPA(N)(実施例2の素材C)、ナタネ由来のリン脂質として、ナタネ由来ペースト状レシチン(実施例2の素材A)、ヒマワリ由来のリン脂質として、ヒマワリ由来粉末状レシチン(実施例2の素材B)をそれぞれ用いた(実施例5~10についても同様)。各サンプルは水とリン脂質のみを含んでいた。これらのサンプルを、官能に関して訓練を受けた者(6~8名)がパネラーとなって下記の基準で評価した。
評価基準
◎:水以外の味を感じない
○:水とは異なるが味を特定できない
△:味を感じる
×:非常に強い味を感じる
上記結果をもとに、◎及び〇の合計人数と△及び×の合計人数を比較し、後者が全人数の半数以上となる濃度を味覚認知閾値の上限値、前記濃度より1段階低い濃度を味覚認知閾値の下限値に設定した。これにより、ダイズ、アブラヤシ、ナタネ及びヒマワリ由来のリン脂質の味覚認知閾値を、それぞれ12.5~25μg/mL、100~150μg/mL、25~50μg/mL及び12.5~25μg/mLと決定した。
1w/v%のショ糖、3.5w/v%のブドウ糖及び208ppmのRebDを純水に溶解したものを対照飲料(Control、甘味強度約8.0)、対照飲料に表21に示す濃度のリン脂質を加えたものを試験飲料とした。これら試験飲料の甘味強度を対照飲料の甘味強度と官能により比較することで甘味増大効果を検証した。評価は、官能に関して訓練を受けた者(6~12名)がパネラーとなり、「対照飲料より甘い」、「対照飲料の方が甘い」、「対照飲料と同じ甘さ」の三肢強制選択法により行った。評価を行った者のうち、対照飲料と比較して試験飲料の甘味が増大していると感じた者の内訳及び割合を表21の結果欄に示した。
1w/v%のショ糖、3.5w/v%のブドウ糖及び208ppmのMogV(純度95%以上(以下の実施例において同じ)、甘味強度約5.6)を純水に溶解したものを対照飲料(Control、甘味強度約8.9)、対照飲料に6.25μg/mLのダイズ由来リン脂質を加えたものを試験飲料とした。試験飲料の甘味強度を対照飲料の甘味強度と官能により比較することで甘味増大効果を検証した。評価は、官能に関して訓練を受けた者(7名)がパネラーとなり、「対照飲料より甘い」、「対照飲料の方が甘い」、「対照飲料と同じ甘さ」の三肢強制選択法により行った。評価を行った者のうち、対照飲料と比較して試験飲料の甘味が増大していると感じた者の数は5名(71%)であった。
実施例5で調製した対照飲料及び試験飲料を用い、試験飲料のテクスチャーを「口当たり(Mouthfeel)」、「厚み・ボディ感(Thickness/Body)」及び「まろやかさ(Mildness)」の評価項目により評価した。各評価項目において、対照飲料と差がない場合を0点とし、-3点から3点まで0.5点刻みで点数付けを行った。対照飲料(Control)よりも口当たりがシロップ様(syrupy)である、厚み・ボディ感を感じる、又はまろやかさを感じる場合は3点に近い点数をつけ、対照飲料よりも甘味の立ち上がりが遅い、口当たりが水様(watery)である、厚み・ボディ感を感じない、又はまろやかさを感じない場合には-3点に近い点数をつけた。すなわち、0点に近いほど対照飲料に近いことを指す。評価は、官能に関して訓練を受けた者(6~10名)がパネラーとなって実施した。結果を図4及び表22に示す。表22の面積比は、対照飲料を1とした場合のレーダーチャートの面積比を示す。
実施例6で調製した対照飲料及び試験飲料を用い、試験飲料のテクスチャーを実施例7と同様に評価した。評価は、官能に関して訓練を受けた者(7名)がパネラーとなって実施した。結果を図5及び表23に示す。表23の面積比は、対照飲料を1とした場合のレーダーチャートの面積比を示す。
実施例5で調製した対照飲料及び試験飲料を用い、試験飲料の甘味の立ち上がりについて評価した。対照飲料と差がない場合を0点とし、-3点から3点まで0.5点刻みで点数付けを行った。対照飲料(Control)よりも甘味の立ち上がりが早い場合は3点に近い点数をつけ、対照飲料よりも甘味の立ち上がりが遅い場合には-3点に近い点数をつけた。すなわち、0点に近いほど対照飲料に近いことを指す。評価は、官能に関して訓練を受けた者(6~10名)がパネラーとなって実施した。結果を表24に示す。
実施例6で調製した対照飲料及び試験飲料を用い、試験飲料の甘味の立ち上がりについて実施例9と同様に評価した。評価は、官能に関して訓練を受けた者(7名)がパネラーとなって実施した。結果は-0.14であった。
1w/v%のショ糖、3.5w/v%のブドウ糖及び208ppmのRebDを純水に溶解したものを対照飲料(Control、甘味強度約8.0)、対照飲料に6.25μg/mLのリン脂質(ダイズ由来、SLP-ホワイト(実施例2の素材I)、特段の記載がない限り以下の実施例において同じ)を加えたものを試験飲料とした。対照飲料と試験飲料の甘味強度を、官能に関して訓練を受けた者(n=6)がパネラーとなってVisual Analogue Scale(VAS)を用いて測定した。パネラーは、左端が「甘味を感じない」、右端を「甘味をこれ以上考えられない程感じる」と定めた直線上に、その時に感じられる甘味の強さをプロットし、左端からの距離を甘味強度の指標とした。その結果、対照飲料の甘味強度を8とした場合の試験飲料の甘味強度は10.2であり、甘味強度は約28%増加した。
355.2ppmのRebDを純水に溶解したものを対照飲料(Control)、対照飲料に6.3μg/mLのリン脂質を加えたものを試験飲料とした。この試験飲料の甘味強度を対照飲料の甘味強度と官能により比較することで甘味増大効果を検証した。評価は、官能に関して訓練を受けた者(7名)がパネラーとなり、「対照飲料より甘い」、「対照飲料の方が甘い」、「対照飲料と同じ甘さ」の三肢強制選択法により行った。評価を行った者のうち、対照飲料と比較して試験飲料の甘味が増大していると感じた者は7人中3人(43%)、対照飲料と試験飲料の甘味が同じと感じた者は7人中1人(14%)であった。
実施例12で調製した対照飲料及び試験飲料を用い、試験飲料のテクスチャーを実施例7と同じ手法で官能評価した。評価は、官能に関して訓練を受けた者(7名)がパネラーとなって実施した。その結果、口当たり、厚み・ボディ感、まろやかさ及びレーダーチャートの面積比は、それぞれ0.07、0.14、0.36及び1.41であった(図6)。なお、レーダーチャートの面積比は、対照飲料を1とした場合のレーダーチャートの面積比を示す。
実施例11で調製した対照飲料及び試験飲料を用い、試験飲料の甘味の立ち上がりを実施例9と同じ手法で官能評価した。評価は、官能に関して訓練を受けた者(7名)がパネラーとなって実施した。その結果、甘味の立ち上がりは-0.21であった。
下表25に示した比率でショ糖、ブドウ糖、RebD及びリン脂質から選択される成分をコーヒー抽出液1000gに添加、混合し、コーヒー飲料サンプルを調製した。各飲料サンプルは、以下の官能試験に供するまで冷蔵保管した。
下表27に示した比率でショ糖、ブドウ糖、RebA(純度95%以上)、RebM(純度95%以上)、MogV、羅漢果抽出物(40重量%のMogVを含有する、羅漢果果実の水性抽出物)及びリン脂質から選択される成分をコーヒー抽出液1000gに添加、混合し、コーヒー飲料サンプルを調製した。各飲料サンプルは、以下の官能試験に供するまで冷蔵保管した。
下表29に示した比率でショ糖、ブドウ糖、RebD及びリン脂質から選択される成分をコーヒー抽出液1000gに添加、混合し、コーヒー飲料サンプルを調製した。各飲料サンプルは、以下の官能試験に供するまで冷蔵保管した。
下表31に示した比率で脱脂粉乳、ショ糖、ブドウ糖、RebD及びリン脂質から選択される成分をコーヒー抽出液1000gに添加、混合し、ミルク入りコーヒー飲料サンプルを調製した。各飲料サンプルは、以下の官能試験に供するまで冷蔵保管した。
下表33に示した比率でショ糖、ブドウ糖、RebD及びリン脂質(ナタネ由来ペースト状レシチン(実施例2の素材A)又はヒマワリ由来粉末状レシチン(実施例2の素材B))から選択される成分をコーヒー抽出液1000gに添加、混合し、コーヒー飲料サンプルを調製した。各飲料サンプルは、以下の官能試験に供するまで冷蔵保管した。
下表35に示した比率で脱脂粉乳、ショ糖、ブドウ糖、RebD及びリン脂質(ナタネ由来ペースト状レシチン(実施例2の素材A)又はヒマワリ由来粉末状レシチン(実施例2の素材B))から選択される成分をコーヒー抽出液1000gに添加、混合し、ミルク入りコーヒー飲料サンプルを調製した。各飲料サンプルは、以下の官能試験に供するまで冷蔵保管した。
Claims (11)
- (a)甘味強度X1相当の量の高甘味度甘味料、
(b)固有のリン脂質、及び
(c)味覚認知閾値未満の異種リン脂質
を含み、
前記成分(a)及び(b)により甘味強度X2の甘味を、前記成分(a)~(c)により甘味強度X3の甘味をそれぞれ呈し、0.1<X2<X3である、経口組成物。 - 前記リン脂質が、炭素数16以上の脂肪酸を有する、請求項1に記載の経口組成物。
- 低甘味度甘味料をさらに含む、請求項1又は2に記載の経口組成物。
- 前記高甘味度甘味料が、ステビア抽出物、羅漢果抽出物、ステビオール配糖体、モグロシド及びその組合せから選択される高甘味度甘味料を含む、請求項1~3のいずれか一項に記載の経口組成物。
- 前記低甘味度甘味料が、ブドウ糖、ショ糖、果糖、麦芽糖、異性化糖、乳糖、プシコース、アロース、タガトース、キシロース、リボース及びその組合せから選択される低甘味度甘味料を含む、請求項3又は4に記載の経口組成物。
- 飲料である、請求項1~5のいずれか一項に記載の経口組成物。
- 飲料が、コーヒー飲料、乳飲料、乳性飲料及び豆乳飲料から選択される、請求項6に記載の経口組成物。
- 固有のリン脂質がコーヒー豆に由来するリン脂質であり、異種リン脂質がダイズ、ナタネ、ヒマワリ、アブラヤシ、ゴマ、トウモロコシ、ラッカセイ、オリーブ、ワタ、アマ、卵黄及び乳から選択される材料に由来するリン脂質である、請求項1~7のいずれか一項に記載の経口組成物。
- 固有のリン脂質を含む経口組成物の原材料に
(a)甘味強度X1相当の量の高甘味度甘味料を添加すること、及び
(b)味覚認知閾値未満のリン脂質を添加すること
を含む、請求項1~8のいずれか一項に記載の経口組成物の製造方法。 - 固有のリン脂質を含む経口組成物の製造において、
(a)味覚認知閾値以上の高甘味度甘味料を添加すること、及び
(b)味覚認知閾値未満のリン脂質を添加すること
を含む、高甘味度甘味料により付与される経口組成物の甘味を増強する方法。 - (a)約20~約600ppmの高甘味度甘味料、
(b)固有のリン脂質、及び
(c)約250μg/mL未満のリン脂質
を含む、経口組成物。
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP21915341.8A EP4268613A4 (en) | 2020-12-28 | 2021-12-28 | ORAL COMPOSITION WITH ENHANCED SWEETNESS |
JP2022573126A JPWO2022145483A1 (ja) | 2020-12-28 | 2021-12-28 | |
US18/269,852 US20240164423A1 (en) | 2020-12-28 | 2021-12-28 | Oral composition with increased sweetness |
AU2021411874A AU2021411874A1 (en) | 2020-12-28 | 2021-12-28 | Oral composition with increased sweetness |
CN202180094674.0A CN116887698A (zh) | 2020-12-28 | 2021-12-28 | 甜味增强的口服组合物 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020-218717 | 2020-12-28 | ||
JP2020218717 | 2020-12-28 | ||
JP2021-144319 | 2021-09-03 | ||
JP2021144319 | 2021-09-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022145483A1 true WO2022145483A1 (ja) | 2022-07-07 |
Family
ID=82260830
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2021/048993 WO2022145483A1 (ja) | 2020-12-28 | 2021-12-28 | 甘味の増大した経口組成物 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20240164423A1 (ja) |
EP (1) | EP4268613A4 (ja) |
JP (1) | JPWO2022145483A1 (ja) |
AU (1) | AU2021411874A1 (ja) |
WO (1) | WO2022145483A1 (ja) |
Citations (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001346555A (ja) * | 2000-06-07 | 2001-12-18 | Senju Shokuhin Kk | 植物抽出エキス飲料、およびその製造方法 |
US6368651B1 (en) * | 1999-05-13 | 2002-04-09 | The Nutrasweet Company | Use of additives to modify the taste characteristics of N-neohexyl-α-aspartyl-L-phenylalanine methyl ester |
JP2003265103A (ja) * | 2002-03-19 | 2003-09-24 | Snow Brand Milk Prod Co Ltd | 呈味性乳化油脂組成物 |
CN103689741A (zh) * | 2013-12-11 | 2014-04-02 | 广东省农业科学院蚕业与农产品加工研究所 | 一种酶法结合乳酸发酵制备米糠饮料的方法 |
JP2016529893A (ja) * | 2013-08-02 | 2016-09-29 | テート アンド ライル イングリーディエンツ アメリカズ エルエルシー | 甘味組成物 |
WO2018225817A1 (ja) | 2017-06-08 | 2018-12-13 | サントリーホールディングス株式会社 | 甘味の増大した飲食品 |
WO2020116624A1 (ja) | 2018-12-07 | 2020-06-11 | サントリーホールディングス株式会社 | 糖および甘味料の呈する味質が改善した茶飲料 |
WO2020116627A1 (ja) | 2018-12-07 | 2020-06-11 | サントリーホールディングス株式会社 | 糖および甘味料の呈する味質が改善したフレーバーウォーター |
WO2020116641A1 (ja) | 2018-12-07 | 2020-06-11 | サントリーホールディングス株式会社 | 糖および甘味料の呈する味質が改善した発泡性飲料 |
WO2020116638A1 (ja) | 2018-12-07 | 2020-06-11 | サントリーホールディングス株式会社 | 糖および甘味料の呈する味質が改善したコーヒー飲料 |
WO2020116628A1 (ja) | 2018-12-07 | 2020-06-11 | サントリーホールディングス株式会社 | 糖および甘味料の呈する味質が改善した茶飲料 |
WO2020116633A1 (ja) | 2018-12-07 | 2020-06-11 | サントリーホールディングス株式会社 | 糖および甘味料の呈する味質が改善した果汁飲料 |
WO2020116626A1 (ja) | 2018-12-07 | 2020-06-11 | サントリーホールディングス株式会社 | 糖および甘味料の呈する味質が改善した果汁飲料 |
WO2020116637A1 (ja) | 2018-12-07 | 2020-06-11 | サントリーホールディングス株式会社 | 糖および甘味料の呈する味質が改善したコーヒー飲料 |
WO2020116634A1 (ja) | 2018-12-07 | 2020-06-11 | サントリーホールディングス株式会社 | 糖および甘味料の呈する味質が改善したフレーバーウォーター |
WO2020116639A1 (ja) | 2018-12-07 | 2020-06-11 | サントリーホールディングス株式会社 | 糖および甘味料の呈する味質が改善した発泡性飲料 |
JP2021144319A (ja) | 2020-03-10 | 2021-09-24 | 株式会社リコー | 情報処理システム、情報処理装置、方法およびプログラム |
-
2021
- 2021-12-28 WO PCT/JP2021/048993 patent/WO2022145483A1/ja active Application Filing
- 2021-12-28 US US18/269,852 patent/US20240164423A1/en active Pending
- 2021-12-28 AU AU2021411874A patent/AU2021411874A1/en active Pending
- 2021-12-28 EP EP21915341.8A patent/EP4268613A4/en active Pending
- 2021-12-28 JP JP2022573126A patent/JPWO2022145483A1/ja active Pending
Patent Citations (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6368651B1 (en) * | 1999-05-13 | 2002-04-09 | The Nutrasweet Company | Use of additives to modify the taste characteristics of N-neohexyl-α-aspartyl-L-phenylalanine methyl ester |
JP2001346555A (ja) * | 2000-06-07 | 2001-12-18 | Senju Shokuhin Kk | 植物抽出エキス飲料、およびその製造方法 |
JP2003265103A (ja) * | 2002-03-19 | 2003-09-24 | Snow Brand Milk Prod Co Ltd | 呈味性乳化油脂組成物 |
JP2016529893A (ja) * | 2013-08-02 | 2016-09-29 | テート アンド ライル イングリーディエンツ アメリカズ エルエルシー | 甘味組成物 |
CN103689741A (zh) * | 2013-12-11 | 2014-04-02 | 广东省农业科学院蚕业与农产品加工研究所 | 一种酶法结合乳酸发酵制备米糠饮料的方法 |
WO2018225817A1 (ja) | 2017-06-08 | 2018-12-13 | サントリーホールディングス株式会社 | 甘味の増大した飲食品 |
WO2020116641A1 (ja) | 2018-12-07 | 2020-06-11 | サントリーホールディングス株式会社 | 糖および甘味料の呈する味質が改善した発泡性飲料 |
WO2020116627A1 (ja) | 2018-12-07 | 2020-06-11 | サントリーホールディングス株式会社 | 糖および甘味料の呈する味質が改善したフレーバーウォーター |
WO2020116624A1 (ja) | 2018-12-07 | 2020-06-11 | サントリーホールディングス株式会社 | 糖および甘味料の呈する味質が改善した茶飲料 |
WO2020116638A1 (ja) | 2018-12-07 | 2020-06-11 | サントリーホールディングス株式会社 | 糖および甘味料の呈する味質が改善したコーヒー飲料 |
WO2020116628A1 (ja) | 2018-12-07 | 2020-06-11 | サントリーホールディングス株式会社 | 糖および甘味料の呈する味質が改善した茶飲料 |
WO2020116633A1 (ja) | 2018-12-07 | 2020-06-11 | サントリーホールディングス株式会社 | 糖および甘味料の呈する味質が改善した果汁飲料 |
WO2020116626A1 (ja) | 2018-12-07 | 2020-06-11 | サントリーホールディングス株式会社 | 糖および甘味料の呈する味質が改善した果汁飲料 |
WO2020116637A1 (ja) | 2018-12-07 | 2020-06-11 | サントリーホールディングス株式会社 | 糖および甘味料の呈する味質が改善したコーヒー飲料 |
WO2020116634A1 (ja) | 2018-12-07 | 2020-06-11 | サントリーホールディングス株式会社 | 糖および甘味料の呈する味質が改善したフレーバーウォーター |
WO2020116639A1 (ja) | 2018-12-07 | 2020-06-11 | サントリーホールディングス株式会社 | 糖および甘味料の呈する味質が改善した発泡性飲料 |
JP2021144319A (ja) | 2020-03-10 | 2021-09-24 | 株式会社リコー | 情報処理システム、情報処理装置、方法およびプログラム |
Non-Patent Citations (10)
Title |
---|
EUR J CLIN NUTR, vol. 58, 2004, pages 629 - 636 |
FERNSTROM J. D.MUNGER S. D.SCLAFANI ADE ARAUJO I. E.ROBERTS AMOLINARY S, J. NUTR., vol. 142, 2012, pages 1134 - 1141 |
LI XSTASZEWSKI LXU HDURICK KZOLLER MADLER E, PROC NATL ACAD SCI USA., vol. 99, no. 7, 2002, pages 4692 - 4696 |
REIKO OHMORI: "The bulletin of the Faculty of Education", vol. 63, 2013, UTSUNOMIYA UNIVERSITY, article "Comparisons of the taste sensitivity between three generations", pages: 201 - 210 |
See also references of EP4268613A4 |
SUZUKI HIDEO: "Vegetable oil production process and phosphorus recovery", SEIBUTSU KOGAKU KAISHI = BIOTECHNOLOGY, vol. 90, no. 8, 1 January 2012 (2012-01-01), JP , pages 488 - 492, XP055948138, ISSN: 0919-3758 * |
TOYOTA ET AL.: "Construction of a Screening Test for Gustatory Function in Four Basic Tastes", THE JOURNAL OF JAPANESE SOCIETY OF STOMATOGNATHIC FUNCTION, vol. 20, 2014, pages 115 - 129 |
YUKI YAMAUCHI: " WHOLE MOUTH GUSTATORY TEST (PART1) - BASIC CONSIDERATIONS AND PRINCIPAL COMPONENT ANALYSIS", JOURNAL OF THE OTO-RHINO-LARYNGOLOGICAL SOCIETY OF JAPAN, vol. 98, no. 1, 1995, pages 119 - 129 |
ZHAO G. QZHANG YHOON M. A.CHANDRASHEKAR JERLENBACH IRYBA N. J. P.ZUKERL C. S, CELL, vol. 115, 2003, pages 255 - 266 |
ZHOU LI, KHALIL ALI, BINDLER FRANÇOISE, ZHAO MINJIE, MARCIC CHRISTOPHE, ENNAHAR SAÏD, MARCHIONI ERIC: "Effect of heat treatment on the content of individual phospholipids in coffee beans", FOOD CHEMISTRY, vol. 141, no. 4, 1 December 2013 (2013-12-01), NL , pages 3846 - 3850, XP055947670, ISSN: 0308-8146, DOI: 10.1016/j.foodchem.2013.06.056 * |
Also Published As
Publication number | Publication date |
---|---|
JPWO2022145483A1 (ja) | 2022-07-07 |
EP4268613A1 (en) | 2023-11-01 |
EP4268613A4 (en) | 2024-08-14 |
US20240164423A1 (en) | 2024-05-23 |
AU2021411874A1 (en) | 2023-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11202462B2 (en) | Rebaudioside A and stevioside compositions | |
ES2817049T5 (es) | Extracto de estevia que contiene glucósidos de esteviol seleccionados como modificador del perfil de gusto, sabor y dulzor | |
JP2019058179A (ja) | レバウディオサイドbを含有するステビアブレンド | |
JP2023123803A (ja) | 甘味受容体(t1r2/t1r3)以外も甘味応答せしめる甘味組成物 | |
WO2018229776A1 (en) | Dairy-based sugar substitute | |
WO2021132468A1 (ja) | 甘味の増大した経口組成物 | |
WO2017156432A1 (en) | Steviol glycoside esters | |
AU2019393560A1 (en) | Coffee beverage having improved quality of taste exhibited by sugar and sweetener | |
US20190350240A1 (en) | Electrolyte-Enhanced Sweetener and Consumable Products Obtained | |
AU2015313804B2 (en) | A flavor modifying composition, uses thereof and products comprising the same | |
JP2013513393A (ja) | 後味のマスキング | |
JP2011254783A (ja) | 甘味増強剤、飲食品及び甘味増強方法 | |
WO2022145483A1 (ja) | 甘味の増大した経口組成物 | |
WO2022145484A1 (ja) | 甘味の増大した経口組成物 | |
WO2022145481A1 (ja) | 甘味の増大した経口組成物 | |
CN116887698A (zh) | 甜味增强的口服组合物 | |
US20240065298A1 (en) | Oral composition having increased sweetness | |
CN114845568A (zh) | 甜味增强的口服组合物 | |
CN116887697A (zh) | 甜味增强的口服组合物 | |
Kim et al. | Effects of aroma–taste interaction on the sensory attributes of rebaudiosides in soymilk and milk | |
CN116669568A (zh) | 甜味增强的口服组合物 | |
CN116634878A (zh) | 甜味增强的口服组合物 | |
US20240114943A1 (en) | Taste-improving compositions and uses thereof | |
AU2022424493A1 (en) | Oral composition having increased sweetness | |
CN117915785A (zh) | 感官改性剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21915341 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2022573126 Country of ref document: JP Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2021411874 Country of ref document: AU Date of ref document: 20211228 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2021915341 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2021915341 Country of ref document: EP Effective date: 20230728 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 202180094674.0 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11202304965S Country of ref document: SG |